1
|
Chopra HK, Nair T, Wander GS, Ponde CK, Ray S, Khullar D, Nanda NC, Narula J, Kasliwal RR, Rana DS, Kirpalani A, Sawhney JPS, Chandra P, Mehta Y, Kumar V, Tewari S, Pancholia AK, Kher V, Bansal S, Mittal S, Kerkar P, Sahoo PK, Hotchandani R, Prakash S, Chauhan N, Rastogi V, Jabir A, Shanmugasundaram S, Tiwaskar M, Sinha A, Gupta V, Mishra SS, Routray SN, Omar AK, Swami OC, Jaswal A, Alam S, Passey R, Rajput R, Paul J, Kapoor A, Prabhakar D, Chandra S, Malhotra P, Singh VP, Bansal M, Shah P, Jain S, Bhargava M, Vijayalakshmi IB, Varghaese K, Jain D, Goel A, Mehmood K, Gaur N, Tandon R, Moorthy A, George S, Katyal VK, Mantri RR, Mehrotra R, Bhalla D, Mittal V, Rao S, Jagia M, Singh H, Awasthi S, Sattur A, Mishra R, Pandey A, Chawla R, Jaggi S, Sehgal B, Sehgal A, Goel N, Gupta R, Kubba S, Chhabra A, Bagga S, Shastry NR. Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from India. J Assoc Physicians India 2024; 72:63-73. [PMID: 38736076 DOI: 10.59556/japi.71.0440] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/14/2024]
Abstract
Heart failure (HF) is a global health concern that is prevalent in India as well. HF is reported at a younger age in Indian patients with comorbidity of type 2 diabetes (T2DM) in approximately 50% of patients. Sodium-glucose cotransporter-2 inhibitors (SGLT2i), originally approved for T2DM, are new guideline-recommended and approved treatment strategies for HF. Extensive evidence highlights that SGLT2i exhibits profound cardiovascular (CV) benefits beyond glycemic control. SGLT2i, in conjunction with other guideline-directed medical therapies (GMDT), has additive effects in improving heart function and reducing adverse HF outcomes. The benefits of SGLT2i are across a spectrum of patients, with and without diabetes, suggesting their potential place in broader HF populations irrespective of ejection fraction (EF). This consensus builds on the updated evidence of the efficacy and safety of SGLT2i in HF and recommends its place in therapy with a focus on Indian patients with HF.
Collapse
Affiliation(s)
- H K Chopra
- Senior Consultant, Department of Cardiology, Medanta Moolchand Heart Center, Delhi, India
| | - Tiny Nair
- Head, Department of Cardiology, PRS Hospital, Trivandrum, Kerala, India
| | - G S Wander
- Professor, Department of Cardiology, Dayanand Medical College & Hospital (DMCH); Hero DMC Heart Institute, Ludhiana, Punjab, India, Corresponding Author
| | - C K Ponde
- Consultant Cardiologist and Head, Department of Cardiology, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India
| | - Saumitra Ray
- Director, Department of Invasive Cardiology, AMRI Hospital, Kolkata, West Bengal, India
| | - Dinesh Khullar
- Chairman-Nephrology and Renal Transplant Medicine, Department of Nephrology and Renal Transplant Medicine, Max Super Speciality Hospital, Delhi, India
| | - Navin C Nanda
- Distinguished Professor, Department of Medicine and Cardiovascular Disease, Division of Cardiology, University of Alabama at Birmingham, Birmingham, Alabama USA
| | - Jagat Narula
- Executive Vice President & Chief Academic Officer, University of Texas, Houston K. Lance Gould, Distinguished University Chair for Coronary Pathophysiology, Distinguished Professor of Medicine & Cardiology McGovern Medical School, Houston Texas, USA
| | - Ravi R Kasliwal
- Chairman, Department of Clinical and Preventive Cardiology, Medanta-The Medicity, Gurugram, Haryana, India
| | - D S Rana
- Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi, India
| | - Ashok Kirpalani
- Consultant Nephrologist, Bombay Hospital, Mumbai, Maharashtra, India
| | - J P S Sawhney
- Chief of Clinical and Preventive Cardiology, Chairman, Department of Cardiology, Sir Gangaram Hospital, Delhi, India
| | - Praveen Chandra
- Chairman, Department of Interventional and Structural Heart Cardiology, Medanta-The Medicity, Gurugram, Haryana, India
| | - Yatin Mehta
- Director, Department of Critical Care Medicine, Medanta Institute of Critical Care Anaesthesiology, Medanta, The Medicity, Gurugram, Haryana, India
| | - Viveka Kumar
- Principal Director and Chief of Cath Labs (Pan Max), Department of Cardiac Sciences, Max Hospital, Delhi, India
| | - S Tewari
- Professor, Department of Cardiology at SGPGIMS, Lucknow, Uttar Pradesh, India
| | - A K Pancholia
- Head of Department, Department of Clinical and Preventive Cardiology, Arihant Hospital and Research Centre, Indore, Madhya Pradesh, India
| | - Vijay Kher
- Chairman, Department of Nephrology; Department of Kidney Transplant, Epitome Kidney Urology Institute and Lions Hospital, Delhi, India
| | - Sandeep Bansal
- Consultant in Cardiology, Professor and Head, Department of Cardiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi, India
| | - Sanjay Mittal
- Senior Cardiologist, Medanta-The Medicity, Gurugram, Haryana, India
| | - Praful Kerkar
- Senior Consultant Interventional Cardiologist, Asian Heart Institute, Mumbai, Maharashtra, India
| | - P K Sahoo
- Interventional Cardiology, Department of Cardiology, Apollo Hospital, Bhubaneshwar, Odisha, India
| | - Ramesh Hotchandani
- Consultant, Head, Department of Nephrology, Moolchand Centre for Renal Care and Dialysis, Moolchand Hospital, Delhi, India
| | - Sunil Prakash
- Senior Director and Head, Department of Nephrology and Renal Transplantation, BLK-Max Super Speciality Hospital, Delhi, India
| | - Nagendra Chauhan
- Senior Cardiologist, Medanta-The Medicity, Gurugram, Haryana, India
| | - Vishal Rastogi
- Director, Department of Interventional Cardiology, Head of Advanced Heart Failure Program, Fortis Escort Heart Institute, Delhi, India
| | - A Jabir
- Senior Cardiologist and Assistant Professor, Lisie Hospital, Cochin, Kerala, India
| | | | - Mangesh Tiwaskar
- Consultant Physician and Diabetologist, Shilpa Medical Research Centre, Mumbai, Maharashtra, India
| | - Ajay Sinha
- Senior Consultant, Department of Cardiology, Medanta Heart Institute, Patna, Bihar, India
| | - Vittul Gupta
- Consulting Physician, Department of Internal Medicine, Kishori Ram Hospital and Diabetes Care Centre, Bhatinda, Punjab, India
| | - S S Mishra
- Director and Senior Consultant Cardiologist, Med N Heart Clinic, Cuttack, Odisha, India
| | - S N Routray
- Professor and Head, Department of Cardiology, SCB Medical College, Cuttack, Odisha, India
| | - A K Omar
- Director, Fortis Escorts Heart Institute, Department of Non-invasive Cardiology, Delhi, India
| | - Onkar C Swami
- Senior Vice President, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India
| | - Aparna Jaswal
- Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute, Delhi, India
| | - Shamsad Alam
- Consultant Interventional Cardiologist, Jayprabha Medanta Super Speciality Hospital, Patna, Bihar, India
| | - Rajeev Passey
- Consultant Cardiologist, Sir Ganga Ram Hospital, Delhi, India
| | - Rajeeve Rajput
- Senior Consultant Cardiologist, Apollo Hospitals, Delhi, India
| | - Justin Paul
- Professor of Cardiology, Madras Medical College, Chennai, Tamil Nadu, India
| | - Aditya Kapoor
- Head, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
| | - D Prabhakar
- Consultant Interventional Cardiologist, Ashwin Clinic, Chennai, Tamil Nadu, India
| | - Subhash Chandra
- Chairman and Head, Department of Cardiology and Structural Heart Disease, BLK Max Super Speciality Hospital, Delhi, India
| | - Poonam Malhotra
- Senior Professor, Department of Cardiac Anaesthesia, All India Institute of Medical Sciences, Delhi, India
| | - Vivudh Pratap Singh
- Senior Consultant, Interventional Cardiologist, Fortis Escort Heart Institute, Delhi, India
| | - Manish Bansal
- Senior Cardiologist, Medanta-The Medicity, Gurugram, Haryana, India
| | - Priyank Shah
- Assistant General Manager, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India
| | - Sanjay Jain
- Associate Vice President, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India
| | - Mohan Bhargava
- Director of Cardiology and Interventional Cardiologist, Max Hospital, Delhi, India
| | - I B Vijayalakshmi
- Professor Emeritus, Former Head Cardiology, Shri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India
| | - Kiron Varghaese
- Professor and Former Head, Department of Cardiology, St. John's Medical College, Bengaluru, Karnataka, India
| | - Dharmender Jain
- Professor and Former Head, Department of Cardiology, IMS, BHU, Varanasi, Uttar Pradesh, India
| | - Anupam Goel
- Director, Interventional Cardiology, Max Super-speciality hospital, Delhi, India, India
| | - Kiran Mehmood
- Assistant Professor, Department of Medicine and Cardiology, Icahn School of Medicine at Mount Sinai; Director, Heart Failure Program, Mount Sinai Morningside Hospital, New York, USA
| | - Namrata Gaur
- CVTS, AIIMS Rishikesh, Rishikesh, Uttarakhand, India
| | - Rohit Tandon
- Consultant, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
| | - Asha Moorthy
- Senior Consultant Cardiologist, SIMS Hospital, Chennai, Tamil Nadu, India
| | - Sheeba George
- Senior Interventional Cardiologist & Head of Cardiology, Department of Interventional Cardiology, Jubilee Memorial Hospital, Trivandrum, Kerala, India
| | - V K Katyal
- Head of Department, Department of General Medicine, Positron Hospital; Formerly Senior Professor, Department of Medicine, Pt BD Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
| | - R R Mantri
- Director, Department of Cardiology, Sir Ganga Ram Hospital, Delhi, India
| | - Rahul Mehrotra
- Director and Head, Department of Non-invasive Cardiology, Max Super Speciality Hospital, Delhi, India
| | - Dilip Bhalla
- Senior Director, Department of Nephrology and Renal Transplant, Max Super Speciality Hospital, Delhi, India
| | - Vinod Mittal
- Senior Consultant Diabetologist and Head, Centre for Diabetes and Metabolic Diseases, Heart and Lung Institute, Delhi, India
| | - Sarita Rao
- Senior Interventional Cardiologist, Director Cath Lab, Apollo Hospital, Indore, Madhya Pradesh, India
| | - Manish Jagia
- Director, Department of Anaesthesia and Critical care, Moolchand Hospital, Delhi, India
| | - Harmeet Singh
- Consultant, Critical Care Specialist, Max Super Speciality Hospital, Ghaziabad, Uttar Pradesh, India
| | - Surabhi Awasthi
- Consultant, Critical Care Specialist, Moolchand Hospital, Delhi, India
| | - Ameet Sattur
- Director of Cath Lab HCG, Suchiraya Hospital, Hubli, Karnataka, India
| | - Rekha Mishra
- Consultant Cardiologist, Indraprastha, Apollo Hospital, Delhi, India
| | - Anand Pandey
- Senior Consultant Cardiologist, Department of Cardiology, Kailash Deepak Hospital, Delhi, India
| | - Rajeev Chawla
- Senior Consultant Diabetologist and Director of North Delhi Diabetes and Cardiac Centre, Delhi, India
| | - Shalini Jaggi
- Consultant Diabetologist and Head, Dr Mohan Diabetes Specialities Centre, Delhi, India
| | - Blessy Sehgal
- Senior Consultant, Nephrology, Shree Balaji Action Medical Institute, Delhi, India
| | - Alok Sehgal
- Head of Department and Chief Interventional Cardiologist, Yeshoda Super Speciality Hospital, Ghaziabad, Uttar Pradesh, India
| | - Naresh Goel
- Director and HOD, Department of Cardiology and HF, Fortis Shalimar Bagh Hospital, Delhi, India
| | - Ripen Gupta
- Interventional Cardiologist, Max Super Speciality Hospital, Delhi, India
| | - Samir Kubba
- Director and Unit Head, Department of Cardiology, Dharmshila Narayana Superspeciality Hospital, Delhi, India
| | | | - Saurabh Bagga
- Senior Cardiologist, Medanta-The Medicity, Gurugram, Haryana, India
| | - N R Shastry
- Consultant Cardiologist, Medanta Moolchand Heart Center, Delhi, India
| |
Collapse
|
2
|
Chopra HK, Wander GS, Ponde CK, Nanda NC, Khullar D, Venugopal K, Ray S, Nair T, Rana DS, Kher V, Sawhney J, Kasliwal RR, Abdullakutty J, Chakraborty R, Chandra P, Bansal S, Kumar V, Pancholia AK, Kapoor A, Prakash S, Saxena A, Rastogi V, Sharma V, Arora YK, Dasbiswas A, Bhargava M, Jaswal A, Bhargava K, Bhatia M, Omar AK, Khanna NN, Passey R, Bhalla D, Vijayalakshmi IB, Bhalla AK, Moorthy A, Isser HS, Mishra SS, Routray S, Tandon V, Sinha A, Bansal M, Jain P, Hotchandani R, Jain D, Katyal VK, Gulati S, Tandon R, Jaggi S, Sehgal B, Gupta V, Mehrotra R, Krishnamani NC, Pathak SN, Yadav MS, Chawla R, Shastry NR, Chatterjee N, Samajdar SS, Pal J, Tiwaskar M. The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22 nd May 2022. J Assoc Physicians India 2024; 72:88-95. [PMID: 38736080 DOI: 10.59556/japi.71.0400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/14/2024]
Abstract
The rapidly increasing burden of hypertension is responsible for premature deaths from cardiovascular disease (CVD), renal disease, and stroke, with a tremendous public health and financial burden. Hypertension detection, treatment, and control vary worldwide; it is still low, particularly in low- and middle-income countries (LMICs). High blood pressure (BP) and CVD risk have a strong, linear, and independent association. They contribute to alarming numbers of all-cause and CVD deaths. A major culprit for increased hypertension is sympathetic activity, and further complications of hypertension are heart failure, ischemic heart disease (IHD), stroke, and renal failure. Now, antihypertensive interventions have emerged as a global public health priority to reduce BP-related morbidity and mortality. Calcium channel blockers (CCB) are highly effective vasodilators. and the most common drugs used for managing hypertension and CVD. Cilnidipine, with both L- and N-type calcium channel blocking activity, is a promising 4th generation CCB. It causes vasodilation via L-type calcium channel blockade and inhibits the sympathetic nervous system (SNS) via N-type calcium channel blockade. Cilnidipine, which acts as a dual L/N-type CCB, is linked to a reduced occurrence of pedal edema compared to amlodipine, which solely blocks L-type calcium channels. The antihypertensive properties of cilnidipine are very substantial, with low BP variability and long-acting properties. It is beneficial for hypertensive patients to deal with morning hypertension and for patients with abnormal nocturnal BP due to exaggerated sympathetic nerve activation. Besides its BP-lowering effect, it also exhibits organ protection via sympathetic nerve inhibition and renin-angiotensin-aldosterone system inhibition; it controls heart rate and proteinuria. Reno-protective, neuroprotective, and cardioprotective effects of cilnidipine have been well-documented and demonstrated.
Collapse
Affiliation(s)
- Hirday Kumar Chopra
- Senior Consultant Cardiologist, Department of Cardiology, Medanta-Moolchand Heart Centre; Chairman CME, Moolchand Medcity, Delhi, India; Country Head, American Heart Association; Chairman, World Wellness Foundation and World Heart Academy, Ludhiana, Punjab, India
| | - Gurpreet S Wander
- Professor and Head of Cardiology, Department of Cardiology, Hero DMC Heart Institute, Dayanand Medical College & Hospital, Ludhiana, Punjab, India
| | - Chandrashekhar K Ponde
- Consultant Cardiologist and Head of Department, Department of Cardiology in PD Hinduja Hospital & Medical Research Centre, Mumbai, Maharashtra, India
| | - Navin C Nanda
- Professor of Medicine and Cardiovascular Disease, Department of Medicine, UAB Heersink School of Medicine, University of Alabama at Birmingham (UAB), Birmingham, Alabama, United States of America
| | - Dinesh Khullar
- Chairman, Department of Nephrology and Renal Transplant Medicine, Max Super Speciality Hospital, Delhi, India
| | - K Venugopal
- Emeritus Professor, Department of Cardiology, Pushpagiri Institute of Medical Sciences, Thiruvalla, Kerala, India
| | - Saumitra Ray
- Director, Department of Invasive Cardiology, AMRI Hospitals, Kolkata, West Bengal, India
| | - Tiny Nair
- Head, Department of Cardiology, PRS Hospital, Trivandrum, Kerala, India
| | - D S Rana
- Emeritus Consultant Nephrologist, Department of Nephrology, Sir Ganga Ram Hospital, Delhi, India
| | - Vijay Kher
- Chairman, Department of Nephrology and Kidney Transplant, Epitome Kidney Urology Institute & Lions Hospital, Delhi, India
| | - Jps Sawhney
- Chairman, Department of Cardiology, Sir Ganga Ram Hospital, Delhi, India
| | - R R Kasliwal
- Adjunct Professor Cardiology (NBE), Chairman, Department of Clinical and Preventive Cardiology, Medanta Heart Institute, Medanta - The Medicity, Gurugram, Haryana, India
| | - Jabir Abdullakutty
- Senior Consultant Cardiologist, Department of Cardiology, Lisie Hospital, Kochi, Kerala, India
| | - Rabin Chakraborty
- Senior Vice Chairman and Head of Cardiology, Department of Cardiology, Medica Super Specialty Hospitals, Kolkata, West Bengal, India
| | - Praveen Chandra
- Chairman, Department of Interventional Cardiology, Medanta Heart Institute, Medanta - The Medicity, Delhi, India
| | - Sandeep Bansal
- Professor and HOD, Department of Cardiology, Safdarjung Hospital, Delhi, India
| | - Viveka Kumar
- Principal Director and Chief of Cath Lab, Department of Cardiac Sciences, Max Super Speciality Hospital, Delhi, India
| | - Arvind K Pancholia
- HOD, Department of Medicine and Preventive Cardiology, Arihant Hospital, Indore, Madhya Pradesh, India
| | - Aditya Kapoor
- Professor and Head, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
| | - Sunil Prakash
- Director and Head, Department of Nephrology and Transplant Service, BLK-Max Super Speciality Hospital, Delhi; Max Hospital, Gurugram, Haryana, India
| | - Anil Saxena
- Executive Director, Department of Cardiac Pacing and Electrophysiology, National Heart Institute of All India Heart Foundation, Delhi, India
| | - Vishal Rastogi
- Director, Department of Cardiology, Fortis Escorts Heart Institute, National Heart Institute of All India Heart Foundation, Delhi, India
| | - Vinod Sharma
- Vice CEO and Head, Department of Cardiology Services, National Heart Institute of All India Heart Foundation, Delhi, India
| | - Y K Arora
- Cardiologist, Department of Cardiology, National Heart Institute, Delhi, India
| | - Arup Dasbiswas
- Ex-Director, Department of ICVS (Cardioogy), Institute of Post Graduate Medical Education & Research (IPGMER); Chief Cardiologist, Department of Cardiology, Dasbiswas Clinic, Kolkata, West Bengal, India
| | - Mohan Bhargava
- Director, Department of Interventional Cardiology, Max Super Speciality Hospital, Delhi, India
| | - Aparna Jaswal
- Member, Board of Directors, The International Board of Heart Rhythm Examiners (IBHRE); Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute, Delhi, India
| | - Kartikeya Bhargava
- Senior Director, Department of Cardiac Electrophysiology and Pacing, Medanta-The Medicity, Gurugram, Haryana, India
| | - Mona Bhatia
- Principal Director and Head, Department of Imaging, Fortis Escorts Heart Institute; Delhi, India
| | - Ashok K Omar
- Director and Head, Department of Noninvasive Cardiology and Heart Command Centre, Fortis Escorts Heart Institute; Delhi, India
| | - Narendra Nath Khanna
- Advisor, Apollo Group of Hospitals; Senior Consultant and Coordinator, Department of Cardiology and Vascular Services, Indraprastha Apollo Hospital; Delhi, India
| | - Rajiv Passey
- Consultant Cardiologist, Department of Cardiology, Sir Ganga Ram Hospital; Delhi, India
| | - Dilip Bhalla
- Senior Director, Department of Nephrology and Renal Transplant, Max Super Specialty Hospital; Delhi, India
| | - I B Vijayalakshmi
- Professor Emeritus, Former HOD, Department of Pediatric Cardiology, Shri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India
| | - Anil Kumar Bhalla
- Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi, India
| | - Asha Moorthy
- Senior Consultant Cardiologist, Department of Cardiology, Shrikrishna Institute of Management and Science, Chennai, Tamil Nadu, India
| | - Harmohander S Isser
- Department of Cardiology, Vardhman Mahavir Medical College & Safdarjung Hospital, Delhi, India
| | - S S Mishra
- Cardiologist, Department of Cardiology, Med N Heart Clinic, Cuttack, Odisha, India
| | - Satyanarayan Routray
- Professor, Department of Cardiology, Srirama Chandra Bhanj Medical College & Hospital (SCB Medical College), Cuttack, Odisha, India
| | - Vivek Tandon
- Associate Director, In-charge, Department of Cardiology, Noninvasive Cardiac Laboratory, Max Smart Super Speciality Hospital, Delhi, India
| | - Ajay Sinha
- Senior Consultant Cardiologist, Department of Cardiology, Jay Prabha Medanta Super Speciality Hospital, Patna, Bihar, India
| | - Manish Bansal
- Senior Director, Department of Clinical and Preventive Cardiology, Medanta-The Medicity, Gurugram, Haryana, India
| | - Praveen Jain
- Executive Director and Chief Cardiologist, Department of Cardiology, Lifeline Superspeciality Hospital & Heart Centre, Jhansi, Uttar Pradesh, India
| | - Ramesh Hotchandani
- Consultant and Head, Department of Nephrology and Transplant, Moolchand Hospital, Delhi, India
| | - Dharmendra Jain
- Professor, Department of Cardiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
| | - V K Katyal
- HOD, Department of Medicine, Positron Multi-speciality Hospital; Formerly Senior Professor and HOD, Department of Medicine, Pt BD Sharma Postgraduate Medical Institute of Medical Science, Rohtak, Haryana, India
| | - Sanjiv Gulati
- Principal Director, Department of Nephrology and Kidney Transplant, Fortis Healthcare, Delhi, India
| | - Rohit Tandon
- Senior Consultant Physician, Department of Cardiology, Hero DMC Heart Institute, Ludhiana, Punjab, India
| | - Shalini Jaggi
- Director and Consultant Diabetologist, Lifecare Diabetes Centre, Delhi, India
| | - Blessy Sehgal
- Consultant Nephrologist, Department of Nephrology, Sri Balaji Action Medical Institute, Delhi, India
| | - Vitull Gupta
- Honorary Teaching Faculty, All India Institute of Medical Sciences; Consultant Physician, Kishori Ram Hospital, Bathinda, Punjab, India
| | - Rahul Mehrotra
- Director and Head, Department of Noninvasive Cardiology, Max Super Speciality Hospital, Delhi, India
| | - N C Krishnamani
- Cardiologist, Department of Cardiac Sciences, Fortis Healthcare, Delhi, India
| | - S N Pathak
- Senior Consultant, Department of Interventional Cardiology, Indraprastha Apollo Hospital, Delhi, India
| | - M S Yadav
- Senior Consultant, Department of Interventional Cardiology, Max Super Speciality Hospital, Delhi, India
| | - Rajeev Chawla
- Senior Consultant Diabetologist, Director, North Delhi Diabetes Centre, Delhi, India
| | - N R Shastry
- Consultant, Department of Noninvasive Cardiology, Medanta Moolchand Heart Centre, Delhi, India
| | - Nandini Chatterjee
- Professor, Department of Internal Medicine, Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata, West Bengal, India
| | - Shambo Samrat Samajdar
- Clinical Pharmacologist and Consultant Physician, Department of Pharmacology, Diabetes and Allergy-Asthma Therapeutics Specialty Clinic; Independent Clinical Pharmacologist, Kolkata, West Bengal, India, Corresponding Author
| | - Jyotirmoy Pal
- Professor, Department of Medicine, R G Kar Medical College & Hospital, SDMC; Dean, Indian College of Physicians, Kolkata, West Bengal, India
| | - Mangesh Tiwaskar
- Consultant Physician and Diabetologist, Shilpa Medical Research Centre, Mumbai, Maharashtra; Editor-in-Chief, Journal of the Association of Physicians of India
| |
Collapse
|
3
|
Chopra HK, Nair T, Wander GS, Ponde CK, Ray S, Khullar D, Nanda NC, Kasliwal RR, Rana DS, Kirpalani A, Sawhney JPS, Chandra P, Mehta Y, Kumar V, Tewari S, Pancholia AK, Kher V, Bansal S, Mittal S, Kerkar P, Sahoo PK, Hotchandani R, Prakash S, Chauhan N, Rastogi V, Jabir A, Shanmugasundaram S, Tiwaskar M, Sinha A, Gupta V, Mishra SS, Routray SN, Omar AK, Swami OC, Jaswal A, Alam S, Passey R, Rajput R, Paul J, Kapoor A, Prabhakar D, Chandra S, Malhotra P, Singh VP, Bansal M, Shah P, Jain S, Bhargava M, Vijayalakshmi IB, Varghaese K, Jain D, Goel A, Gaur N, Tandon R, Moorthy A, George S, Katyal VK, Mantri RR, Mehrotra R, Bhalla D, Mittal V, Rao S, Jagia M, Singh H, Awasthi S, Sattur A, Mishra R, Pandey A, Chawla R, Jaggi S, Sehgal B, Sehgal A, Goel N, Gupta R, Kubba S, Chhabra A, Bagga S, Shastry NR. Role of Bisoprolol in Heart Failure Management: A Consensus Statement from India. J Assoc Physicians India 2023; 71:77-88. [PMID: 38736057 DOI: 10.59556/japi.71.0426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/14/2024]
Abstract
In India, heart failure (HF) is an important health concern affecting younger age groups than the western population. A limited number of Indian patients receive guideline-directed medical therapy (GDMT). Selective β-1 blockers (BB) are one of the GDMTs in HF and play an important role by decreasing the sympathetic overdrive. The BB reduces heart rate (HR) reverse the adverse cardiac (both ventricular and atrial), vascular, and renovascular remodeling seen in HF. Bisoprolol, a β-1 blocker, has several advantages and can be used across a wide spectrum of HF presentations and in patients with HF and comorbid conditions such as coronary artery disease (CAD), atrial fibrillation (AF), post-myocardial infarction (MI), uncontrolled diabetes, uncontrolled hypertension, and renal impairment. Despite its advantages, bisoprolol is not optimally utilized for managing HF in India. This consensus builds on updated evidence on the efficacy and safety of bisoprolol in HF and recommends its place in therapy with a focus on Indian patients with HF.
Collapse
Affiliation(s)
- H K Chopra
- Senior Consultant, Department of Cardiology, Medanta Moolchand Heart Center, Delhi, India
| | - Tiny Nair
- Head, Department of Cardiology, PRS Hospital, Trivandrum, Kerala, India
| | - G S Wander
- Professor, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India, Corresponding Author
| | - C K Ponde
- Consultant Cardiologist and Head, Department of Cardiology, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra, India
| | - Saumitra Ray
- Director, Department of Invasive Cardiology, AMRI Hospital, Kolkata, West Bengal, India
| | - Dinesh Khullar
- Chairman, Nephrology and Renal transplant Medicine, Dept. of Nephrology and Renal transplant medicine, Max Super-speciality Hospital, Delhi, India
| | - Navin C Nanda
- Distinguished Professor of Medicine and Cardiovascular Disease, Division of Cardiology, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Ravi R Kasliwal
- Chairman, Department of Clinical and Preventive Cardiology, Medanta-The Medicity, Gurgaon, Haryana, India
| | - D S Rana
- Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi, India
| | - Ashok Kirpalani
- Consultant Nephrologist, Bombay Hospital, Mumbai, Maharashtra, India
| | - J P S Sawhney
- Chief of Clinical and Preventive Cardiology, Chairman, Department of Cardiology, Sir Gangaram Hospital, Delhi, India
| | - Praveen Chandra
- Chairman, Department of Interventional and Structural Heart Cardiology, Medanta - The Medicity, Gurgaon, Haryana, India
| | - Yatin Mehta
- Director, Dept of Critical care medicine, Medanta Institute of Critical care Anaesthesiology, Medanta, The Medicity, Gurgaon, Haryana, India
| | - Viveka Kumar
- Principal Director and Chief of Cath Labs (Pan Max), Department of Cardiac Sciences, Max Hospital, Delhi, India
| | - S Tewari
- Professor of Cardiology at SGPGIMS, Lucknow, Uttar Pradesh, India
| | - A K Pancholia
- Head of Department, Department of Clinical and Preventive Cardiology, Arihant Hospital and Research Centre, Indore, Madhya Pradesh, India
| | - Vijay Kher
- Chairman, Department of Nephrology, Department of Kidney Transplant, Epitome Kidney Urology Institute and Lions Hospital, Delhi, India
| | - Sandeep Bansal
- Consultant in Cardiology, Professor and Head, Department of Cardiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi, India
| | - Sanjay Mittal
- Senior Cardiologist, Medanta-The Medicity ,Gurgaon, Haryana, India
| | - Praful Kerkar
- Senior Consultant Interventional Cardiologist, Asian Heart Institute, Mumbai, Maharashtra, India
| | - P K Sahoo
- Interventional Cardiology, Department of Cardiology, Apollo Hospital, Bhubaneshwar, Odisha, India
| | - Ramesh Hotchandani
- Consultant, Head, Department of Nephrology, Moolchand Centre for Renal Care and Dialysis, Moolchand Hospital, Delhi, India
| | - Sunil Prakash
- Senior Director and Head, Department of Nephrology and Renal Transplantation, BLK-Max Super Speciality Hospital, Delhi, India
| | - Nagendra Chauhan
- Senior Cardiologist, Medanta-The Medicity ,Gurgaon, Haryana, India
| | - Vishal Rastogi
- Director, Department of Interventional Cardiology, Head of Advanced Heart Failure Program, Fortis Escort Heart Institute, Delhi, India
| | - A Jabir
- Senior Cardiologist and Assistant Professor, Lisie Hospital, Cochin, Kerala, India
| | | | - Mangesh Tiwaskar
- Consultant Physician and Diabetologist, Shilpa Medical Research Centre, Mumbai, Maharashtra, India
| | - Ajay Sinha
- Senior Consultant, Department of Cardiology, Medanta Heart Institute, Patna, Bihar, India
| | - Vittul Gupta
- Consulting Physician, Department of Internal Medicine, Kishori Ram Hospital and Diabetes Care Centre, Bhatinda, Punjab, India
| | - S S Mishra
- Director and Senior Consultant Cardiologist, Med N Heart Clinic, Cuttack, Odisha, India
| | - S N Routray
- Professor and Head, Department of Cardiology, SCB Medical College, Cuttack, Odisha, India
| | - A K Omar
- Director, Fortis Escorts Heart Institute, Department of Non-invasive Cardiology, Delhi, India
| | - Onkar C Swami
- Sr. Vice President, Medical Services, Alembic Pharmaceuticals Ltd, Mumbai, Maharashtra, India
| | - Aparna Jaswal
- Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute, Delhi, India
| | - Shamsad Alam
- Consultant Interventional Cardiologist, Jayprabha Medanta Super Speciality Hospital, Patna, Bihar, India
| | - Rajeev Passey
- Consultant Cardiologist, Sir Ganga Ram Hospital, Delhi, India
| | - Rajeeve Rajput
- Senior Consultant Cardiologist, Apollo Hospitals, Delhi, India
| | - Justin Paul
- Professor of Cardiology, Madras Medical College, Chennai, Tamil Nadu, India
| | - Aditya Kapoor
- Head, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
| | - D Prabhakar
- Consultant Interventional Cardiologist, Ashwin Clinic, Chennai, Tamil Nadu, India
| | - Subhash Chandra
- Chairman and Head, Dept. of Cardiology and Structural Heart Disease, BLK Max Superspeciality Hospital, Delhi, India
| | - Poonam Malhotra
- Senior Professor, Cardiac Anaesthesia, All India Institute of Medical Sciences, Delhi, India
| | - Vivudh Pratap Singh
- Sr. Consultant, Interventional Cardiologist, Fortis Escort Heart Institute, Delhi, India
| | - Manish Bansal
- Senior Cardiologist, Medanta-The Medicity ,Gurgaon, Haryana, India
| | - Priyank Shah
- Assistant General Manager, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India
| | - Sanjay Jain
- Associate Vice President, Medical Services, Alembic Pharmaceuticals Ltd., Mumbai, Maharashtra, India
| | - Mohan Bhargava
- Director of Cardiology and Interventional Cardiologist, Max Hospital, Delhi, India
| | - I B Vijayalakshmi
- Professor Emeritus, Former Head Pediatric Cardiology, Shri Jayadeva Institute of Cardiovascular sciences and Research, Bengaluru, Karnataka, India
| | - Kiron Varghaese
- Professor and Former Head, Department of Cardiology, St. John's Medical College, Bangalore, India
| | - Dharmender Jain
- Professor and Former head, Department of Cardiology, IMS, BHU, Varanasi, Uttar Pradesh, India
| | - Anupam Goel
- Director, Interventional Cardiology, Max Super-speciality hospital, Delhi, India
| | - Namrata Gaur
- CVTS, AIIMS Rishikesh, Rishikesh, Uttarakhand, India
| | - Rohit Tandon
- Consultant, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
| | - Asha Moorthy
- Senior Consultant Cardiologist, SIMS Hospital, Chennai, Tamil Nadu, India
| | - Sheeba George
- Sree Mookambika Institute of Medical Sciences, Thiruvananthapuram, Kerala, India
| | - V K Katyal
- Head of Dept. Department of General Medicine, Positron Hospital; Formerly Senior Professor, Department of Medicine, Pt. B.D.Sharma, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
| | - R R Mantri
- Director, Department of Cardiology, Sir Ganga Ram Hospital, Delhi, India
| | - Rahul Mehrotra
- Director and Head, Department of Non-Invasive Cardiology, Max Super Speciality Hospital, Delhi, India
| | - Dilip Bhalla
- Senior Director, Department of Nephrology and Renal Transplant, Max Super Speciality Hospital, Delhi, India
| | - Vinod Mittal
- Senior Consultant Diabetologist and Head, Centre for Diabetes and Metabolic Diseases, Heart and Lung Institute, Delhi, India
| | - Sarita Rao
- Sr. Interventional Cardiologist, Director Cath Lab, Apollo Hospital, Indore, Madhya Pradesh, India
| | - Manish Jagia
- Director, Department of Anaesthesia and Critical care, Moolchand Hospital, Delhi, India
| | - Harmeet Singh
- Consultant, Critical Care Specialist, Max Super-speciality hospital, Ghaziabad, Uttar Pradesh, India
| | - Surabhi Awasthi
- Consultant, Critical Care Specialist, Moolchand Hospital, Delhi, India
| | - Ameet Sattur
- Director of Cath Lab HCG, Suchiraya Hospital, Hubli, Karnataka, India
| | - Rekha Mishra
- Consultant Cardiologist, Indraprastha, Apollo Hospital, Delhi, India
| | | | - Rajeev Chawla
- Sr. Consultant Diabetologist and Director of North Delhi Diabetes and Cardiac Centre, Delhi, India
| | - Shalini Jaggi
- Consultant Diabetologist and Head at Dr. Mohans Diabetes Specialities Centre, Delhi, India
| | - Blessy Sehgal
- Sr. Consultant Nephrology, Shree Balaji Action Medical Institute, Delhi, India
| | - Alok Sehgal
- Head of Dept. and Chief Interventional Cardiologist, Yeshoda Superspeciality Hospital, Ghaziabad, Uttar Pradesh, India
| | - Naresh Goel
- Sr. cardiologist, Department of Cardiology BLK Super-speciality Hospital, Delhi, India
| | - Ripen Gupta
- Interventional Cardiologist, Max Super Speciality hospital, Delhi, India
| | - Samir Kubba
- Director and Unit Head, Cardiology Department Dharmshila Narayana Superspeciality Hospital, Delhi, India
| | | | - Saurabh Bagga
- Senior Cardiologist, Medanta-The Medicity ,Gurgaon, Haryana, India
| | - N R Shastry
- Consultant Cardiologist, Medanta Moolchand Heart Center, Delhi, India
| |
Collapse
|
4
|
Chopra HK, Wander GS, Nair T, Ponde CK, Nanda NC, Narula J, Ray S, Venugopal K, Iyengar SS, Kasliwal RR, Chandra P, Prakash S, Bansal S, Rana DS, Kerkar P, Dasbiswas A, Sawhney J, Shanmungasundram S, Kumar V, Vijayalakshmi IB, Pancholia AK, Sharma V, Kapoor A, Swami OC, Isser HS, Rastogi V, Arora YK, Omar AK, Sathe S, Rajput R, Prabhakar D, Paul GJ, Jagia P, Malhotra P, Suryaprakash G, Mittal V, Jagia M, Jabir A, Mishra SS, Routray SN, Sinha AK, Bhargava M, Mahmood K, Lal S, Dabhade D, Bhatia M, Kalra P, Katyal VK, Tandon R, Grover R, Chhabra A, Shastry NR. Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from India. J Assoc Physicians India 2023; 71:11-12. [PMID: 37355795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 06/26/2023]
Abstract
Adverse cardiac remodeling refers to progressive structural and functional modifications in the heart because of increased wall stress in the myocardium, loss of viable myocardium, and neurohormonal stimulation. The guideline-directed medical therapy for Heart failure (HF) includes Angiotensin receptor-neprilysin inhibitor (ARNI) (sacubitril/valsartan), β-blockers, sodium-glucose co-transporter 2 (SGLT2) inhibitors, and mineralocorticoid receptor antagonists (MRA). ARNI is under-prescribed in India despite its attractive safety and efficacy profile. Therefore, the consensus discusses objectives and topics related to ARNI in the management of cardiac remodeling, and experts shared their views on the early timely intervention of effective dosage of ARNI to improve the diagnosis and enhance mortality and morbidity benefits in cardiac reverse remodeling (CRR).
Collapse
Affiliation(s)
- H K Chopra
- Senior Consultant, Department of Cardiology, Medanta Moolchand Heart Center, Delhi
| | - G S Wander
- Professor and Head, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab;Corresponding Author
| | - Tiny Nair
- Head, Department of Cardiology, PRS Hospital, Trivandrum, Kerala
| | - C K Ponde
- Consultant Cardiologist and Head, Department of Cardiology, PD Hinduja National Hospital & Medical Research Centre, Mumbai, Maharashtra, India
| | - Navin C Nanda
- Department of Cardiology Division, University of Alabama at Birmingham (UAB), Birmingham, Alabama
| | - Jagat Narula
- Associate Dean, Chief, Icahn School of Medicine at Mount Sinai (ISMMS); Division of Cardiology, Mount Sinai Hospital, New York, United States of America
| | - Saumitra Ray
- Director, Department of Invasive Cardiology, AMRI Hospital, Kolkata, West Bengal
| | - K Venugopal
- Senior Consultant Cardiologist, KVM Hospital Cherthala and SP Fort Hospital, Thiruvananthapuram, Kerala
| | - S S Iyengar
- Consultant Emeritus and Academic Head, Department of Cardiology, Manipal Hospital, Bengaluru, Karnataka
| | - R R Kasliwal
- Chairman, Department of Clinical and Preventive Cardiology, Medanta The Medicity, Gurugram, Haryana
| | - Praveen Chandra
- Chairman, Department of Interventional and Structural Heart Cardiology, Medanta The Medicity, Gurugram, Haryana
| | - Sunil Prakash
- Senior Director and Head, Department of Nephrology and Renal Transplantation, BLK-Max Super Speciality Hospital, Delhi
| | - Sandeep Bansal
- Consultant in Cardiology, Professor and Head, Department of Cardiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi
| | - D S Rana
- Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi
| | - Prafulla Kerkar
- Senior Consultant Interventional Cardiologist, Asian Heart Institute, Mumbai, Maharashtra
| | - Arup Dasbiswas
- Ex Director ICVS, Professor and Head of Department, Department of Cardiology, ICVS; Institute of Postgraduate Medical Education & Research, Kolkata, West Bengal
| | - Jps Sawhney
- Chief of Clinical and Preventive Cardiology, Chairman, Department of Cardiology, Sir Gangaram Hospital, Delhi
| | | | - Viveka Kumar
- Principal Director and Chief of Cath Labs (Pan Max), Department of Cardiac Sciences, Max Hospital, Delhi
| | - I B Vijayalakshmi
- Professor Emeritus, Former Head Pediatric Cardiology, Shri Jayadeva Institute of Cardiovascular sciences and Research, Bengaluru, Karnataka
| | - A K Pancholia
- Head of Department, Department of Clinical and Preventive Cardiology, Arihant Hospital and Research Centre, Indore, Madhya Pradesh
| | - Vinod Sharma
- Head of Cardiology and Vice Chief Executive Officer, National Heart Institute, Delhi
| | - Aditya Kapoor
- Head, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh
| | - Onkar C Swami
- Director, Department of Medical Services, Emcure Pharmaceuticals Ltd., Pune, Maharashtra
| | - H S Isser
- Professor and Consultant, Department of Cardiology, Vardhman Mahavir Medical College and Safdarjung Hospital
| | - Vishal Rastogi
- Director, Department of Interventional Cardiology, Head of Advanced Heart Failure Program, Fortis Escort Heart Institute
| | - Y K Arora
- Consultant Cardiologist, National Heart Institute
| | - Ashok K Omar
- Director, Noninvasive Cardiology and Head Heart Command Centres, Fortis Escorts Heart Institute, Delhi
| | - Sunil Sathe
- Interventional Cardiologist, Ruby Hall Clinic, Pune, Maharashtra
| | | | - D Prabhakar
- Consultant Interventional Cardiologist, Ashwin Clinic, Chennai, Tamil Nadu
| | - G Justin Paul
- Professor of Cardiology, Madras Medical College, Chennai, Tamil Nadu
| | - Priya Jagia
- Professor and Head, Department of Cardiovascular Imaging and Endovascular Interventions, Cardiothoracic Sciences Centre, All India Institute of Medical Sciences, Delhi
| | - Poonam Malhotra
- Senior Professor, Cardiac Anaesthesia, All India Institute of Medical Sciences, Delhi
| | - G Suryaprakash
- Senior Consultant Cardiologist and Clinical Director, Care Hospitals, Hyderabad, Telangana
| | - Vinod Mittal
- Senior Consultant Diabetologist and Head, Centre for Diabetes and Metabolic Diseases, Delhi Heart and Lung Institute
| | - Manish Jagia
- Director, Department of Anaesthesia and Critical care, Moolchand Hospital, Delhi
| | - A Jabir
- Senior Cardiologist and Assistant Professor, Lisie Hospital, Cochin, Kerala
| | - S S Mishra
- Director and Senior Consultant Cardiologist, Med N Heart Clinic, Cuttack, Odisha
| | - S N Routray
- Professor and Head, Department of Cardiology, SCB Medical College, Cuttack, Odisha
| | - Ajay Kumar Sinha
- Senior Consultant, Department of Cardiology, Medanta Heart Institute, Patna, Bihar
| | - Mohan Bhargava
- Director of Cardiology and Interventional Cardiologist, Max hospital, Delhi, India
| | - Kiran Mahmood
- Assistant Professor of Medicine (Cardiology), Icahn School of Medicine at Mount Sinai (ISMMS); Director of Heart Failure Program, Mount Sinai Morningside Hospital, New York, United States of America
| | | | - Dhammdeep Dabhade
- Senior Manager, Department of Medical Services, Emcure Pharmaceuticals Ltd., Pune, Maharashtra
| | - Mona Bhatia
- Principal Director and Head, Department of Radiology and Imaging, Fortis Escorts Heart Institute, Delhi
| | - Pramila Kalra
- Professor and Head, Department of Endocrinology, Ramaiah Medical College and Hospitals, Bengaluru, Karnataka
| | - V K Katyal
- Head of Department, Department of Medicine, Positron Multispecialty and Cancer Hospital, Rohtak, Haryana
| | - Rohit Tandon
- Consultant, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab
| | - Rahul Grover
- Associate Director, Department of Nephrology, Max Hospital, Delhi
| | - Abhinav Chhabra
- Consultant Interventional Cardiologist, Medanta Hospital, Gurugram, Haryana
| | - N R Shastry
- Consultant Cardiologist, Medanta Moolchand Heart Center, Delhi, India
| |
Collapse
|
5
|
Chopra HK, Wander GS, Nair T, Ponde CK, Nanda NC, Narula J, Ray S, Venugopal K, Iyengar SS, Kasliwal RR, Chandra P, Prakash S, Bansal S, Rana DS, Kerkar P, Dasbiswas A, Sawhney J, Shanmungasundram S, Kumar V, Vijayalakshmi IB, Pancholia AK, Sharma V, Kapoor A, Swami OC, Isser HS, Rastogi V, Arora YK, Omar AK, Sathe S, Rajput R, Prabhakar D, Paul GJ, Jagia P, Malhotra P, Suryaprakash G, Mittal V, Jagia M, Jabir A, Mishra SS, Routray SN, Sinha AK, Bhargava M, Mahmood K, Bhatia M, Kalra P, Katyal VK, Tandon R, Grover R, Chhabra A, Shastry NR. Role of Iron Therapy in Heart Failure: A Consensus Statement from India. J Assoc Physicians India 2023; 71:11-12. [PMID: 37354511 DOI: 10.5005/japi-11001-0214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/26/2023]
Abstract
Iron deficiency (ID) with or without anemia is frequently observed in patients with heart failure (HF). Uncorrected ID is associated with higher hospitalization and mortality in patients with acute HF (AHF) and chronic HF (CHF). Hence, in addition to chronic renal insufficiency, anemia, and diabetes, ID appears as a novel comorbidity and a treatment target of CHF. Intravenous (IV) ferric carboxymaltose (FCM) reduces the hospitalization risk due to HF worsening and improves functional capacity and quality of life (QOL) in HF patients. The current consensus document provides criteria, an expert opinion on the diagnosis of ID in HF, patient profiles for IV FCM, and correct administration and monitoring of such patients.
Collapse
Affiliation(s)
- H K Chopra
- Senior Consultant, Department of Cardiology, Medanta Moolchand Heart Institute, Delhi
| | - G S Wander
- Professor and Head, Department of Cardiology, Dayanand Medical College & Hospital (DMCH), Ludhiana, Punjab; Corresponding Author
| | - Tiny Nair
- Head, Department of Cardiology, PRS Hospital, Trivandrum, Kerala
| | - C K Ponde
- Consultant Cardiologist and Head, Department of Cardiology, P. D. Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra
| | - Navin C Nanda
- Department of Cardiology Division, University of Alabama at Birmingham (UAB), Birmingham, Alabama
| | - Jagat Narula
- Associate Dean and Chief, Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai, New York
| | - Saumitra Ray
- Director, Department of Invasive Cardiology, AMRI Hospitals, Kolkata, West Bengal
| | - K Venugopal
- Senior Consultant Cardiologist, KVM Hospital Cherthala and SP Fort Hospital, Trivandrum, Kerala
| | - S S Iyengar
- Consultant Emeritus and Academic Head, Department of Cardiology, Manipal Hospital, Bengaluru, Karnataka
| | - R R Kasliwal
- Chairman, Department of Clinical and Preventive Cardiology, Heart Institute at Medanta, Gurgaon, Haryana
| | - Praveen Chandra
- Chairman, Department of Interventional and Structural Heart Cardiology, Medanta Moolchand Heart Institute, Gurgaon, Haryana
| | - Sunil Prakash
- Senior Director and Head, Department of Nephrology and Renal Transplantation, BLK-Max Super Speciality Hospital, Delhi
| | - Sandeep Bansal
- Consultant in Cardiology, Professor and Head, Department of Cardiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi
| | - D S Rana
- Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi
| | - Prafulla Kerkar
- Senior Consultant Interventional Cardiologist, Asian Heart Institute, Mumbai, Maharashtra
| | - Arup Dasbiswas
- Ex Director ICVS, Professor and Head of Department, Department of Cardiology, ICVS, Institute of Postgraduate Medical Education & Research (IPGMER), Kolkata, West Bengal
| | - Jps Sawhney
- Chief Clinical and Preventive Cardiology and Chairman, Department of Cardiology, Sir Ganga Ram Hospital, Delhi
| | | | - Viveka Kumar
- Principal Director and Chief of Cath Labs (Pan Max), Department of Cardiac Sciences, Max Super Speciality Hospital, Delhi
| | - I B Vijayalakshmi
- Emeritus Professor and Former Head Pediatric Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka
| | - A K Pancholia
- Head of the Department and Clinical and Preventive Cardiology, Arihant Hospital & Research Centre, Indore, Madhya Pradesh
| | - Vinod Sharma
- Head of Cardiology and Vice Chief Executive Officer, National Heart Institute, Delhi
| | - Aditya Kapoor
- Head, Department of Cardiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh
| | - Onkar C Swami
- Director, Department of Medical Services, Emcure Pharmaceuticals Ltd., Pune, Maharashtra
| | - H S Isser
- Professor and Consultant, Department of Cardiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi
| | - Vishal Rastogi
- Director, Head of Advanced Heart Failure Program, Department of Interventional Cardiology, Fortis Escorts Heart Institute, Delhi
| | - Y K Arora
- Consultant Cardiologist, National Heart Institute, Delhi
| | - Ashok K Omar
- Director of Noninvasive Cardiology and Head Heart Command Centers, Fortis Escorts Heart Institute, Delhi
| | - Sunil Sathe
- Interventional Cardiologist, Ruby Hall Clinic, Pune, Maharashtra
| | | | - D Prabhakar
- Consultant Interventional Cardiologist, Ashwin Clinic, Chennai, Tamil Nadu
| | - G J Paul
- Professor of Cardiology, Madras Medical College, Chennai, Tamil Nadu
| | - Priya Jagia
- Professor and Head, Department of Cardiovascular Imaging and Endovascular Interventions, Cardiothoracic Sciences Centre, All India Institute of Medical Sciences, Delhi
| | - Poonam Malhotra
- Senior Professor, Cardiac Anaesthesia, All India Institute of Medical Sciences, Delhi
| | - G Suryaprakash
- Senior Consultant Cardiologist and Clinical Director, Care Hospitals, Hyderabad, Telangana
| | - Vinod Mittal
- Senior Consultant Diabetologist and Head, Centre for Diabetes and Metabolic Diseases, Delhi Heart and Lung Institute, Delhi
| | - Manish Jagia
- Director, Department of Anaesthesia and Critical care, Moolchand Hospital, Delhi
| | - A Jabir
- Senior Cardiologist and Assistant Professor, Lisie Hospital, Kochi, Kerala
| | - S S Mishra
- Director and Senior Consultant Cardiologist, Med N Heart Clinic, Cuttack, Odisha
| | - S N Routray
- Professor and Head, Department of Cardiology, Srirama Chandra Bhanj Medical College & Hospital (S.C.B Medical College), Cuttack, Odisha
| | - Ajay K Sinha
- Senior Consultant, Department of Cardiology, Medanta Heart Institute, Patna, Bihar
| | - Mohan Bhargava
- Director Cardiology and Interventional Cardiologist, Max Super Speciality Hospital, Delhi
| | - Kiran Mahmood
- Assistant Professor of Medicine (Cardiology), Icahn School of Medicine, Mount Sinai; Director of Heart Failure Program, Mount Sinai Morningside Hospital, New York
| | - Mona Bhatia
- Principal Director and Head, Department of Radiology and Imaging, Fortis Escorts Heart Institute, Delhi
| | - Pramila Kalra
- Professor and Head, Department of Endocrinology, Ramaiah Medical College and Hospitals, Bengaluru, Karnataka
| | - V K Katyal
- Head, Department of Medicine, Positron Multispecialty and Cancer Hospital, Rohtak, Haryana
| | - Rohit Tandon
- Consultant, Department of Cardiology, Dayanand Medical College & Hospital (DMCH), Ludhiana, Punjab
| | - Rahul Grover
- Associate Director, Department of Nephrology, Max Super Speciality Hospital, Delhi
| | - Abhinav Chhabra
- Consultant Interventional Cardiologist, Medanta Moolchand Heart Institute, Gurgaon, Haryana
| | - N R Shastry
- Consultant Cardiologist, Medanta Moolchand Heart Institute, Delhi
| |
Collapse
|
6
|
Behera PK, Kaur P, Mishra SS, Mishra SK. Mapping and visualizing the research contribution of India on telemedicine: A scientometric study. J Postgrad Med 2023:370400. [PMID: 36861544 PMCID: PMC10394533 DOI: 10.4103/jpgm.jpgm_107_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023] Open
Abstract
Background The term "Telemedicine" is being used in the medical and health sector to treat patients and to provide medical guidance remotely. The intellectual output from India in terms of publications was harvested from Scopus® with the keyword "Telemedicine" and analyzed by using bibliometric techniques. Methods The source data was downloaded from the Scopus® database. All the publications on telemedicine and indexed in the database up to the year 2021 were considered for scientometric analysis. The software tools VOSviewer® version 1.6.18 to visualize bibliometric networks, statistical software R Studio® version 3.6.1 with the Bibliometrix package Biblioshiny® were used for analysis and data visualization, and EdrawMind® was used for mind mapping. Result India contributed 2,391 (4.32%) publications on telemedicine to a total of 55,304 publications worldwide until 2021. There were 886 (37.05%) papers that appeared in open access mode. The analysis revealed that the first paper was published in the year 1995 from India. Steep growth in the number of publications was observed in 2020 with 458 publications. The highest, 54 research publications, appeared in the "Journal of Medical Systems." The All India Institute of Medical Sciences (AIIMS), New Delhi, contributed the highest number of publications (n = 134). A considerable overseas collaboration was observed (USA: 11%; UK: 5.85%). Conclusions This is the first such attempt to address the intellectual output of India in the emerging medical discipline of telemedicine and has yielded useful information such as leading authors, institutions, their impact, and year-wise topic trends.
Collapse
Affiliation(s)
- P K Behera
- PK Kelkar Library, Indian Institute of Technology, Kanpur, Uttar Pradesh, India
| | - P Kaur
- Central Library, Chandigarh University, Gharuan, Mohali, Punjab, India
| | - S S Mishra
- Centre for Development of Advanced Computing (CDAC), Mohali, Punjab, India
| | - S K Mishra
- Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, Uttar Pradesh, India
| |
Collapse
|
7
|
Chopra HK, Wander GS, Ponde CK, Nanda NC, Khullar D, Venugopal K, Ray S, Nair T, Rana DS, Kher V, S Sawhney JP, Kasliwa RR, Jabir A, Chakraborty R, Chandra P, Bansal S, Kumar V, Pancholia AK, Kapoor A, Prakash S, Saxena A, Rastogi V, Sharma V, Arora YK, Dasbiswas A, Bhargava M, Jaswal A, Bhargava K, Bhatia M, Omar AK, Khanna NN, Passey R, Bhalla D, Vijayalakshmi IB, Bhalla AK, Moorthy A, Isser HS, Mishra SS, Routray SN, Tandon V, Sinha A, Bansal M, Jain P, Hotchandani R, Jain D, Katyal VK, Gulati S, Tandon R, Jaggi S, Sehgal B, Gupta V, Mehrotra R, Krishnamani NC, Pathak SN, Yadav MS, Chawla R, Pal J, Chatterjee N, Samajdar SS, Shastry NR. The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus Statement. J Assoc Physicians India 2023; 71:11-12. [PMID: 37354473 DOI: 10.5005/japi-11001-0209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/26/2023]
Abstract
;Heart failure (HF) is a huge global public health task due to morbidity, mortality, disturbed quality of life, and major economic burden. It is an area of active research and newer treatment strategies are evolving. Recently angiotensin receptor-neprilysin inhibitor (ARNI), a class of drugs (the first agent in this class, Sacubitril-Valsartan), reduces cardiovascular mortality and morbidity in chronic HF patients with reduced left ventricular ejection fraction (LVEF). Positive therapeutic effects have led to a decrease in cardiovascular mortality and HF hospitalizations (HFH), with a favorable safety profile, and have been documented in several clinical studies with an unquestionable survival benefit with ARNI, Sacubitril-Valsartan. This consensus statement of the Indian group of experts in cardiology, nephrology, and diabetes provides a comprehensive review of the power and promise of ARNI in HF management and an evidence-based appraisal of the use of ARNI as an essential treatment strategy for HF patients in clinical practice. Consensus in this review favors an early utility of Sacubitril-Valsartan in patients with HF with reduced EF (HFrEF), regardless of the previous therapy being given. A lower rate of hospitalizations for HF with Sacubitril-Valsartan in HF patients with preserved EF who are phenotypically heterogeneous suggests possible benefits of ARNI in patients having 40-50% of LVEF, frequent subtle systolic dysfunction, and higher hospitalization risk.
Collapse
Affiliation(s)
- H K Chopra
- Senior Consultant Cardiologist, Medanta Moolchand Heart Institute, Delhi
| | - G S Wander
- Professor & Head of Cardiology, Hero DMC Heart Institute, Dayanand Medical College & Hospital (DMCH), Ludhiana, Punjab
| | - C K Ponde
- Consultant Cardiologist and Head of Department, Department of Cardiology, P. D. Hinduja Hospital & Medical Research Centre, Mumbai, Maharashtra, India
| | - Navin C Nanda
- Professor of Medicine and Cardiovascular Disease, Heersink School of Medicine, University of Alabama at Birmingham (UAB), Birmingham, United Kingdom
| | - Dinesh Khullar
- Chairman, Department of Nephrology; Department of Kidney Transplant, Max Super Speciality Hospital, Delhi
| | - K Venugopal
- Professor Emeritus, Department of Cardiology, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala
| | - Saumitra Ray
- Director, Department of Invasive Cardiology, AMRI Hospitals, Kolkata, West Bengal
| | - Tiny Nair
- Head, Department of Cardiology & Interventional Cardiology, PRS Hospital, Trivandrum, Kerala
| | - D S Rana
- Emeritus Consultant Nephrologist, Department of Nephrology, Sir Ganga Ram Hospital
| | - Vijay Kher
- Chairman; Department of Nephrology; Department of Kidney Transplant, Epitome Kidney Urology Institute & Lions Hospital
| | - J P S Sawhney
- Chairman, Department of Cardiology, Sir Ganga Ram Hospital, New Delhi, Delhi
| | - R R Kasliwa
- Adjunct Professor, Department of Cardiology; Chairman, Department of Clinical and Preventive Cardiology, Medanta Moolchand Heart Institute, Gurugram, Haryana
| | - A Jabir
- Senior Consultant Cardiologist, Lisie Hospital, Kochi, Kerala
| | - Rabin Chakraborty
- Senior Vice Chairman and Head of Cardiology, Medica Superspecialty Hospital (MSH), Kolkata, West Bengal
| | - Praveen Chandra
- Chairman, Department of Interventional Cardiology, Medanta Moolchand Heart Institute
| | - Sandeep Bansal
- Professor and HOD, Department of Cardiology, Safdarjung Hospital
| | - Viveka Kumar
- Principal Director and Chief of Cath Lab, Department of Cardiac Sciences, Max Super Speciality Hospital, Delhi
| | - A K Pancholia
- HOD, Department of Medicine and Preventive Cardiology, Arihant Hospital & Research Centre, Indore, Madhya Pradesh
| | - Aditya Kapoor
- Professor and Head of the Department, Department of Cardiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences
| | - Sunil Prakash
- Director and Head, Department of Nephrology; Department of Transplant service BLK, Max Super Speciality Hospital
| | - Anil Saxena
- Executive Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute
| | - Vishal Rastogi
- Director of Cardiology, Department of Cardiology, Fortis Escorts Heart Institute
| | - Vinod Sharma
- Vice CEO and Head, Department of Cardiology, National Heart Institute
| | - Y K Arora
- Cardiologist, National Heart Institute, Delhi
| | - Arup Dasbiswas
- Ex-Director, ICVS, Institute of Post Graduate Medical Education and Research (IPGME&R); Chief Cardiologist, Das Biswas Clinic, Kolkata, West Bengal
| | - Mohan Bhargava
- Director, Department of Interventional Cardiology, Max Super Speciality Hospital, Delhi, India
| | - Aparna Jaswal
- Member, Board of Directors, International Board of Heart Rhythm Examiners, Columbia, Washington, United States of America; Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute
| | - K Bhargava
- Senior Director, Department of Cardiac Electrophysiology and Pacing, Medanta Moolchand Heart Institute
| | - Mona Bhatia
- Principal, Director, Head, Department of Imaging, Fortis Escorts Heart Institute
| | - A K Omar
- Director, Head, Department of Non-Invasive Cardiology, Fortis Escorts Heart Institute
| | - N N Khanna
- Advisor, Senior Consultant, Department of Cardiology, Indraprastha Apollo Hospitals
| | | | - Dilip Bhalla
- Senior Director, Department of Nephrology and Renal Transplant, Max Super Speciality Hospital, Delhi
| | - I B Vijayalakshmi
- Professor Emeritus, Former HOD, Department of Paediatric Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka
| | - A K Bhalla
- Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi
| | - Asha Moorthy
- Senior Consultant Cardiologist, SIMS Hospital, Chennai, Tamil Nadu
| | - H S Isser
- Department of Cardiology, VMMC & Safdarjung Hospital
| | | | - S N Routray
- Professor, Department of Cardiology, Srirama Chandra Bhanj Medical College & Hospital (S.C.B Medical College), Cuttack, Odisha
| | - Vivek Tandon
- Associate Director, In charge, Non-Invasive Cardiac Laboratory, Max Smart Super Speciality Hospital, Delhi
| | - Ajay Sinha
- Senior Consultant, Cardiologist, Jay Prabha Medanta Super Specialty Hospital, Patna, Bihar
| | - Manish Bansal
- Senior Director, Department Clinical and Preventive Cardiology, Medanta - The Medicity Multi-Speciality Hospital, Gurugram, Haryana
| | - Praveen Jain
- Executive Director, Chief Cardiologist, Lifeline Superspeciality Hospital and Heart Center, Jhansi, Uttar Pradesh
| | - Ramesh Hotchandani
- Consultant, Head, Department of Nephrology, Moolchand Centre for Renal Care and Dialysis, Moolchand Hospital, Delhi
| | - Dharmendra Jain
- Professor, Department of Cardiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh
| | - V K Katyal
- HOD, Department of General Medicine, Positron Hospital; Formerly Senior Professor, HOD, Department of Medicine, Pt. B.D.Sharma, Post Graduate Institute of Medical Sciences, Rohtak, Haryana
| | - Sanjiv Gulati
- Principal Director, Department of Nephrology, Fortis Hospital, Delhi
| | - Rohit Tandon
- Senior Consultant Physician, Department of Cardiology, Hero DMC Heart Institute, Dayanand Medical College & Hospital (DMCH), Ludhiana, Punjab
| | - Shalini Jaggi
- Director, Consultant Diabetologist, Lifecare Diabetes Centre
| | - Blessy Sehgal
- Consultant Nephrologist, Department of Nephrology, Sri Balaji Action Medical Institute, Delhi
| | - Vitull Gupta
- Honorary Teaching Faculty, All India Institute of Medical Sciences; Consultant Physician, Kishori Ram Hospital, Bathinda, Punjab
| | - Rahul Mehrotra
- Director and Head, Department of Non-Invasive Cardiology, Max Super Speciality Hospital
| | | | - S N Pathak
- Senior Consultant Interventional Cardiologist, Indraprastha Apollo Hospital
| | - M S Yadav
- Senior Consultant, Department of Interventional Cardiology, Max Super Speciality Hospital
| | - Rajeev Chawla
- Senior Consultant Diabetologist, Director, North Delhi Diabetes Centre, Delhi
| | - Jyotirmoy Pal
- Professor, Department of General Medicine, R.G. Kar Medical College & Hospital
| | - Nandini Chatterjee
- Clinical Pharmacologist, Diabetes & Allergy-Asthma Therapeutics Specialty Clinic
| | - Shambo S Samajdar
- Professor, Department of Medicine, Institute of Post Graduate Medical Education and Research (IPGME&R) - SSKM Hospital
| | - N R Shastry
- Cardiologist, Department of Clinical Cardiology, Medanta-Moolchand Heart Centre, Delhi, India
| |
Collapse
|
8
|
V J, Mishra SS, Mb KU, Thomas SP, Tiwary CS, Biswas K, Kamble VB. Highly Sensitive and Selective Triethylamine Sensing through High-Entropy Alloy (Ti-Zr-Cr-V-Ni) Nanoparticle-Induced Fermi Energy Control of MoS 2 Nanosheets. ACS Appl Mater Interfaces 2022; 14:13653-13664. [PMID: 35276048 DOI: 10.1021/acsami.2c00531] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
A giant enhancement of nearly 100 times is seen in triethylamine response through Ti-Zr-Cr-V-Ni high-entropy alloy nanoparticle (HEA NP)-induced fermi energy control of two-dimensional molybdenum disulfide (MoS2) nanosheets. These Laves-phase HEA NP-decorated MoS2 samples are synthesized using cryomilling followed by 30 h of sonication. The prolonged sonication results in well-exfoliated MoS2 with fairly small (∼10-20 nm) HEA NPs anchored due to cryomilling confirmed by extensive microscopic and spectroscopic examinations. The presence of HEA NPs leads to reduction in edge oxidation of MoS2 as seen from X-ray photoelectron spectroscopy. Moreover, this edge state reduction causes strong Fermi level pinning, which is commonly observed in layered MoS2 with bulk metal electrodes. This leads to target gas-specific carrier-type response and selective oxidation of TEA vapors due to highly catalytically active metals. The resulting composite (MoS2 + NPs) exhibits high response (380% for 2000 ppm TEA vapors) along with selectivity toward TEA at 50 °C. The cross-sensitivity of the composite to other volatile organic compounds and NH3, CO, and H2 has been very minimal. Thus, the highly selective catalytic activity of metal alloy NPs and their Fermi energy control has been proposed as the prime factors for observed large sensitivity and selective response of MoS2 + NP nanocomposites.
Collapse
Affiliation(s)
- Jishnu V
- School of Physics, Indian Institute of Science Education and Research, Thiruvananthapuram, Kerala 695551, India
| | - Shashank Shekhar Mishra
- Department of Materials Science and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India
| | - Kusuma Urs Mb
- School of Physics, Indian Institute of Science Education and Research, Thiruvananthapuram, Kerala 695551, India
| | - Sanchu P Thomas
- School of Physics, Indian Institute of Science Education and Research, Thiruvananthapuram, Kerala 695551, India
| | - Chandra Sekhar Tiwary
- Metallurgical and Materials Engineering, Indian Institute of Technology Kharagpur, Kharagpur 382355, India
| | - Krishanu Biswas
- Department of Materials Science and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India
| | - Vinayak B Kamble
- School of Physics, Indian Institute of Science Education and Research, Thiruvananthapuram, Kerala 695551, India
| |
Collapse
|
9
|
Sharma S, Shekhar Mishra S, Kumar RP, Yadav RM. Recent progress on polyvinylidene difluoride based nanocomposite: Applications in energy harvesting and sensing. NEW J CHEM 2022. [DOI: 10.1039/d2nj00002d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Discovered in 2006, Nanogenerators have attracted much attention as promising energy-harvesting devices. It harnesses energy by utilizing piezoelectric, pyroelectric thermoelectric properties of nanomaterials to produce electricity and have potential to...
Collapse
|
10
|
Gupta K, Ramakrishnan S, Zachariah G, Rao JS, Mohanan PP, Venugopal K, Sateesh S, Sethi R, Jain D, Bardolei N, Mani K, Kakar TS, Jain V, Gupta P, Gupta R, Bansal S, Nath RK, Tyagi S, Wander GS, Gupta S, Mandal S, Senguttuvan NB, Subramanyam G, Roy D, Datta S, Ganguly K, Routray SN, Mishra SS, Singh BP, Bharti BB, Das MK, Deb PK, Deedwania P, Seth A. Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey. Int J Cardiol Hypertens 2021; 7:100055. [PMID: 33465185 PMCID: PMC7803035 DOI: 10.1016/j.ijchy.2020.100055] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Revised: 09/27/2020] [Accepted: 09/30/2020] [Indexed: 01/19/2023] Open
Abstract
Background The impact of the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for diagnosis and management of hypertension on the prevalence of hypertension in India is unknown. Methods We analyzed data from the Cardiac Prevent 2015 survey to estimate the change in the prevalence of hypertension. The JNC8 guidelines defined hypertension as a systolic blood pressure of ≥140 mmHg or diastolic blood pressure of ≥90 mmHg. The 2017 ACC/AHA guidelines define hypertension as a systolic blood pressure of ≥130 mmHg or diastolic blood pressure of ≥80 mmHg. We standardized the prevalence as per the 2011 census population of India. We also calculated the prevalence as per the World Health Organization (WHO) World Standard Population (2000–2025). Results Among 180,335 participants (33.2% women), the mean age was 40.6 ± 14.9 years (41.1 ± 15.0 and 39.7 ± 14.7 years in men and women, respectively). Among them, 8,898 (4.9%), 99,791 (55.3%), 35,694 (11.9%), 23,084 (12.8%), 9,989 (5.5%) and 2,878 (1.6%) participants belonged to age group 18–19, 20–44, 45–54, 55–64, 65–74 and ≥ 75 years respectively. The prevalence of hypertension according to the JNC8 and 2017 ACC/AHA guidelines was 29.7% and 63.8%, respectively- an increase of 115%. With the 2011 census population of India, this suggests that currently, 486 million Indian adults have hypertension according to the 2017 ACC/AHA guidelines, an addition of 260 million as compared to the JNC8 guidelines. Conclusion According to the 2017 ACC/AHA guidelines, 3 in every 5 Indian adults have hypertension.
Collapse
Affiliation(s)
- Kartik Gupta
- Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.,Department of Medicine, Henry Ford Hospital, Detroit, MI, USA
| | - Sivasubramanian Ramakrishnan
- Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.,Cardiology Society of India, India
| | | | | | | | | | | | | | | | | | - Kalaivani Mani
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
| | | | - Vardhmaan Jain
- Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA
| | - Prakash Gupta
- Department of Medicine, All India Institute of Medical Sciences, New Delhi, India
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - P K Deb
- Cardiology Society of India, India
| | - Prakash Deedwania
- School of Medicine, University of California, San Francisco Fresno, CA, USA
| | | | | |
Collapse
|
11
|
Mishra SS, Ranjan S, Sharma CS, Singh HP, Kalra S, Kumar N. Computational investigation of potential inhibitors of novel coronavirus 2019 through structure-based virtual screening, molecular dynamics and density functional theory studies. J Biomol Struct Dyn 2020; 39:4449-4461. [PMID: 32666910 PMCID: PMC7441804 DOI: 10.1080/07391102.2020.1791957] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Despite the intensive research efforts towards antiviral drug against COVID-19, no
potential drug or vaccines has not yet discovered. Initially, the binding site of COVID-19
main protease was predicted which located between regions 2 and 3. Structure-based virtual
screening was performed through a hierarchal mode of elimination technique after
generating a grid box. This led to the identification of five top hit molecules that were
selected on the basis of docking score and visualization of non-bonding interactions. The
docking results revealed that the hydrogen bonding and hydrophobic interactions are the
major contributing factors in the stabilization of complexes. The docking scores were
found between −7.524 and −6.711 kcal/mol indicating strong ligand-protein interactions.
Amino acid residues Phe140, Leu141, Gly143, Asn142, Thr26, Glu166 and Thr190 (hydrogen
bonding interactions) and Phe140, Cys145, Cys44, Met49, Leu167, Pro168, Met165, Val42,
Leu27 and Ala191 (hydrophobic interactions) formed the binding pocket of COVID-19 main
protease. From identified hits, ZINC13144609 and ZINC01581128 were selected for atomistic
MD simulation and density functional theory calculations. MD simulation results confirm
that the protein interacting with both hit molecules is stabilized in the chosen POPC
lipid bilayer membrane. The presence of lowest unoccupied molecular orbital (LUMO) and
highest occupied molecular orbital (HOMO) in the hydrophobic region of the hit molecules
leads to favorable ligand-protein contacts. The calculated pharmacokinetic descriptors
were found to be in their acceptable range and therefore confirming their drug-like
properties. Hence, the present investigation can serve as the basis for designing and
developing COVID-19 inhibitors. Communicated by Ramaswamy H. Sarma
Collapse
Affiliation(s)
- Shashank Shekhar Mishra
- Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Bhupal Nobles' University, Udaipur, India
| | - Shashi Ranjan
- Department of Pharmacy, United group of Institutions, Uttar-Pradesh, India
| | - Chandra Shekhar Sharma
- Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Bhupal Nobles' University, Udaipur, India
| | - Hemendra Pratap Singh
- Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Bhupal Nobles' University, Udaipur, India
| | - Sourav Kalra
- Centre for Human Genetics & Molecular Medicine, Central University of Punjab, Bhatinda, India
| | - Neeraj Kumar
- Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Bhupal Nobles' University, Udaipur, India
| |
Collapse
|
12
|
Gupta R, Das MK, Mohanan PP, Deb PK, Parashar SK, Chopra HK, Shrivastava S, Guha S, Goswami KC, Yadav R, Alagesan R, Amuthan V, Bansal M, Chakraborty RN, Chakraborti N, Chandra S, Chatterjee A, Chatterjee D, Chatterjee SS, Dutta AL, De A, Garg A, Garg VK, Goyal A, Goyal NK, Govind SC, Gupta VK, Hasija PK, Jabir A, Jain P, Jain V, Jayagopal PB, Kasliwal RR, Katyal VK, Kerkar PG, Khan AK, Khanna NN, Mandal M, Majumder B, Mishra SS, Meena CB, Naik N, Narain VS, Pancholia AK, Pathak LA, Ponde CK, Raghu K, Ray S, Roy D, Sarma D, Shanmugasundarum S, Singh BP, Tyagi S, Vijayaraghavan G, Wander GS, Wardhan H, Nanda NC. Cardiological society of India document on safety measure during echo evaluation of cardiovascular disease in the time of COVID-19. Indian Heart J 2020; 72:145-150. [PMID: 32768012 PMCID: PMC7250084 DOI: 10.1016/j.ihj.2020.05.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Revised: 05/15/2020] [Accepted: 05/19/2020] [Indexed: 01/08/2023] Open
Abstract
An echocardiographic investigation is one of the key modalities of diagnosis in cardiology. There has been a rising presence of cardiological comorbidities in patients positive for COVID-19. Hence, it is becoming extremely essential to look into the correct safety precautions, healthcare professionals must take while conducting an echo investigation. The decision matrix formulated for conducting an echocardiographic evaluation is based on presence or absence of cardiological comorbidity vis-à-vis positive, suspected or negative for COVID-19. The safety measures have been constructed keeping in mind the current safety precautions by WHO, CDC and MoHFW, India.
Collapse
Affiliation(s)
- Rakesh Gupta
- JROP Institute of Echocardiography, Ultrasound & Vascular Doppler, JROP Healthcare Pvt. Ltd., C-1/16, Ashok Vihar-II, Delhi, 110052, India; JROP Charak Heart City, MD City Hospital, Model Town Northex, Delhi, 110009, India.
| | - Mrinal Kanti Das
- C K Birla Group of Hospitals (BMB and CMRI), Kolkata, West Bengal, India
| | - P P Mohanan
- Westfort Hi-Tech Hospital, Thrissur, Kerala, India
| | | | - S K Parashar
- Metro Heart Hospital, Lajpat Nagar, New Delhi, India
| | | | | | - Santanu Guha
- Calcutta Medical College Hospital, Kolkata, West Bengal, India
| | | | - Rakesh Yadav
- All India Institute of Medical Sciences, New Delhi, India
| | | | - V Amuthan
- Jeyalakshmi Heart Center, Madurai, Tamilnadu, India
| | - M Bansal
- Medanta, The Medicity, New Delhi, India
| | - R N Chakraborty
- Medica Group of Superspeciality Hospitals, Kolkata, West Bengal, India
| | - N Chakraborti
- Medica Group of Superspeciality Hospitals, Kolkata, West Bengal, India
| | - S Chandra
- King George's Medical University, Lucknow, India
| | | | - D Chatterjee
- Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, India
| | | | | | - A De
- Apollo Gleneagles Hospital, Kolkata, India
| | - A Garg
- Jaipur Heart Institute, Jaipur, India
| | - V K Garg
- R D Gardi Medical College, Ujjain, India
| | - A Goyal
- Bani Park Hospital, Jaipur, India
| | - N K Goyal
- BLK Superspeciality Hospital, New Delhi, India
| | | | - V K Gupta
- Kishori Ram Hospital & Diabetes Care Centre, Bhatinda, India
| | | | - A Jabir
- Lisie Hospital Kochi, Kerala, India
| | - P Jain
- Lifeline Superspeciality Hospital, Jhansi, India
| | - V Jain
- Choithram Hospital &R.C., Indore, India
| | | | | | | | | | | | | | - M Mandal
- NRS Medical College, Kolkata, India
| | - B Majumder
- R.G. Kar Medical College & Hospital, Kolkata, India
| | - S S Mishra
- Hi-Tech Medical College and Hospital, Bhubaneshwar, India
| | - C B Meena
- SMS Medical College, Jaipur, Rajasthan
| | | | - V S Narain
- King George's Medical University, Lucknow, India
| | | | - L A Pathak
- Nanavati Heart Institute, Nanavati Superspeciality Hospital, Mumbai, India
| | - C K Ponde
- PD Hinduja National Hospital & RC, Mumbai, India
| | - K Raghu
- Care Hospital, Hyderabad, India
| | - S Ray
- Vivekananda Institute of Medical Sciences, Kolkata, India
| | - D Roy
- Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, India
| | - D Sarma
- Jorhat Christian Medical Centre Hospital, Jorhat, Assam, India
| | | | | | - S Tyagi
- GB Pant Institute of Post Graduate Medical Education and Research, New Delhi, India
| | | | - G S Wander
- Hero DMC Heart Institute, Ludhiana, India
| | - Harsh Wardhan
- Mahatma Gandhi Medical College and Hospital, Jaipur, India
| | - N C Nanda
- University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
13
|
Kerkar PG, Naik N, Alexander T, Bahl VK, Chakraborty RN, Chatterjee SS, Chopra HK, Dani SI, Deb PK, Goswami KC, Guha S, Gupta R, Gupta V, Hasija PK, Jayagopal PB, Justin Paul G, Kahali D, Katyal VK, Khanna NN, Mandal M, Mishra SS, Mohanan PP, Mullasari A, Mehta S, Pancholia AK, Ray S, Roy D, Shanmugasundarm S, Sharma S, Singh BP, Tewari S, Tyagi SK, Venugopal KN, Wander GS, Yadav R, Das MK. Cardiological Society of India: Document on acute MI care during COVID-19. Indian Heart J 2020; 72:70-74. [PMID: 32534693 PMCID: PMC7201231 DOI: 10.1016/j.ihj.2020.04.009] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Accepted: 04/29/2020] [Indexed: 12/20/2022] Open
Abstract
The unprecedented and rapidly spreading Coronavirus Disease-19 (COVID-19) pandemic has challenged public health care systems globally. Based on worldwide experience, India has initiated a nationwide lockdown to prevent the exponential surge of cases. During COVID-19, management of cardiovascular emergencies like acute Myocardial Infarction (MI) may be compromised. Cardiological Society of India (CSI) has ventured in this moment of crisis to evolve a consensus document for care of acute MI. However, this care should be individualized, based on local expertise and governmental advisories.
Collapse
Affiliation(s)
- P G Kerkar
- Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India
| | - N Naik
- All India Institute of Medical Sciences, New Delhi, India
| | - T Alexander
- Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India
| | - V K Bahl
- All India Institute of Medical Sciences, New Delhi, India
| | - R N Chakraborty
- Medica Group of Superspeciality Hospitals, Kolkata, West Bengal, India
| | - S S Chatterjee
- Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
| | | | - S I Dani
- Apollo Hospital, Ahmedabad, Gujarat, India
| | - P K Deb
- Daffodil Hospital, Kolkata, West Bengal, India
| | - K C Goswami
- All India Institute of Medical Sciences, New Delhi, India
| | - S Guha
- Calcutta Medical College Hospital, Kolkata, West Bengal, India
| | - R Gupta
- JROP Healthcare, New Delhi, India
| | - V Gupta
- Kishori Ram Hospital & Diabetes Care Centre, India
| | - P K Hasija
- Armed Forces Medical College, Pune, Maharashtra, India
| | | | | | - D Kahali
- BM Birla Heart Research Center, Kolkata, West Bengal, India
| | - V K Katyal
- Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
| | - N N Khanna
- Indraprastha Apollo Hospital, New Delhi, India
| | - M Mandal
- NRS Medical College and Hospital, Kolkata, West Bengal, India
| | - S S Mishra
- Hi-Tech Medical College and Hospital, Bhubaneshwar, Odisha, India
| | - P P Mohanan
- Westfort Hi-Tech Hospital, Thrissur, Kerala, India
| | - A Mullasari
- Madras Medical Mission Hospital, Chennai, Tamil Nadu, India
| | - S Mehta
- University of Miami, Florida, USA
| | | | - S Ray
- Vivekanand Institute of Medical Sciences, Kolkata, West Bengal, India
| | - D Roy
- Rabindranath Tagore International Institute of Medical Sciences, Kolkata, West Bengal, India
| | | | | | - B P Singh
- Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India
| | - S Tewari
- Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
| | | | - K N Venugopal
- Pushpagiri Institute of Medical Sciences, Tiruvalla, Kerala, India
| | - G S Wander
- Dayanand Medical College, Ludhiana, Punjab, India
| | - R Yadav
- All India Institute of Medical Sciences, New Delhi, India
| | - M K Das
- C K Birla Group of Hospitals (BMB and CMRI), Kolkata, West Bengal, India.
| |
Collapse
|
14
|
Karkara BB, Mishra SS, Singh BN, Panda G. Synthesis of 2-methoxy-3-(thiophen-2-ylmethyl)quinoline containing amino carbinols as antitubercular agents. Bioorg Chem 2020; 99:103775. [PMID: 32222618 DOI: 10.1016/j.bioorg.2020.103775] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2019] [Revised: 02/13/2020] [Accepted: 03/17/2020] [Indexed: 12/13/2022]
Abstract
We have designed and synthesized 2-methoxy-3-(thiophen-2-ylmethyl)quinoline containing amino carbinols as possible anti-tubercular agents to combat the disease. These molecules were synthesized by tethering amino ether linkage with hydroxyl group to diarylquinoline skeleton; hydroxyl and amine chains were engrafted on diaryl ring. They were evaluated against strain (H37Ra) of Mycobacterium tuberculosis and most of compounds showed in vitro antitubercular activity. Two compounds having diaryl quinoline hydroxyl amino ether scaffold and three compounds having diaryl amino alkyl carbinol core showed activities at 6.25 μg/mL. This study explores diaryl carbinol prototype as inhibitor against Mycobacterium tuberculosis.
Collapse
Affiliation(s)
- Bidhu Bhusan Karkara
- Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute BS, 10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Shashank Shekhar Mishra
- Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute BS, 10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India
| | - Bhupendra N Singh
- Microbiology Division, CSIR-Central Drug Research Institute BS 10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India; Academiy of Scientific and Innovative Research, New Delhi 110001, India
| | - Gautam Panda
- Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute BS, 10/1, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow 226031, India; Academiy of Scientific and Innovative Research, New Delhi 110001, India.
| |
Collapse
|
15
|
Yadav MK, Singh SK, Singh M, Mishra SS, Singh AK, Tripathi JS, Tripathi YB. Neuroprotective Activity of Evolvulus alsinoides & Centella asiatica Ethanolic Extracts in Scopolamine-Induced Amnesia in Swiss Albino Mice. Open Access Maced J Med Sci 2019; 7:1059-1066. [PMID: 31049081 PMCID: PMC6490476 DOI: 10.3889/oamjms.2019.247] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2019] [Revised: 03/25/2019] [Accepted: 03/26/2019] [Indexed: 01/15/2023] Open
Abstract
AIM To carry out the comparative nootropic, neuroprotective potentials of two medicinal plant species. MATERIAL AND METHODS For neuroprotective activity; behavior models (elevated plus maze & morris water maze), in vivo antioxidant (superoxide dismutase, catalase, lipid peroxidation & reduced glutathione), inflammatory markers (IL-1β, IL-6 & TNF-α) and acetylcholine esterase (AChE) assessment procedures followed at different dosages i.e. 250 & 500 mg/kg of Evolvulus alsinoides and Centella asiatica ethanolic extracts. At the end of the study, it was performed histopathological analysis of the following organs: brain, heart, liver, and kidney. RESULTS In oral administration of different doses of ethanolic extracts of both medicinal plants i.e. Sco + EEA 250 = 2.49 ± 0.29 , Sco + EEA 500 = 2.67 ± 0.36, Sco + ECA 250 = 2.33 ± 0.17, Sco + ECA 500 = 2.77 ± 0.21, Sco + EEA + ECA 250 = 2.61 ± 0.32 and Sco + EEA + ECA 500 = 2.79 ± 0.16 U/mg of protein respectively against the scopolamine induced group Sco (control) = 5.51 ± 0.35 U/mg of protein extracts shows neuroprotective and nootropic activity with reducing AChE level in the brain homogenate of swiss albino mice. CONCLUSION Since the E. alsinoides & C. asiatica are already used in traditional Indian medicine as the neuroprotective agent and also found promising effects over inflammatory diseases, wound healing, and immunomodulatory activity. The neuroprotective effect of both plants extracts attributed to inhibition of AChE activity and improve the spatial memory formation.
Collapse
Affiliation(s)
- Mukesh Kumar Yadav
- Department of Kayachikitsa, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Santosh Kumar Singh
- Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Manish Singh
- Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Shashank Shekhar Mishra
- Department of Vikriti Vigyan, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Anurag Kumar Singh
- Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Jyoti Shankar Tripathi
- Department of Kayachikitsa, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Yamini Bhusan Tripathi
- Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| |
Collapse
|
16
|
Yadav MK, Singh SK, Singh M, Mishra SS, Singh AK, Tripathi JS, Tripathi YB. In Vivo Toxicity Study of Ethanolic Extracts of Evolvulus alsinoides & Centella asiatica in Swiss Albino Mice. Open Access Maced J Med Sci 2019; 7:1071-1076. [PMID: 31049083 PMCID: PMC6490486 DOI: 10.3889/oamjms.2019.209] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2019] [Revised: 03/04/2019] [Accepted: 03/05/2019] [Indexed: 11/05/2022] Open
Abstract
AIM We aimed to investigate several parameters after the in vivo acute and sub-acute administration of ethanolic extracts from E. alsinoides & C. asiatica. METHODS Malignant Ovarian Germ Cell Tumors for in vivo toxicity study guidelines 423 and 407 of Organization for Economic Co-operation and Development (OECD) were followed for acute and sub-acute toxicity assays respectively. For LD50 evaluation, a single dose of ethanolic extracts of Evolvulus alsinoides L. (EEA) and ethanolic extracts of Centella asiatica (ECA) was orally administered to mice at doses of 200, 400, 800, 1600 and 2000 mg/kg. Then the animals were observed for 72 hours. For acute toxicity evaluation, a single dose of both extracts was orally administered to mice at doses of 300, 600, 1200 and 2000 mg/kg and the animals were observed for 14 days. In the sub-acute study, the extracts were orally administered to mice for 28 days at doses of 300, 600, 1200 and 2000 mg/kg. To assess the toxicological effects, animals were closely observed on general behaviour, clinical signs of toxicity, body weight, food and water intake. At the end of the study, it was performed biochemical and hematological evaluations, as well as histopathological analysis from the following organs: brain, heart, liver, and kidney. RESULTS The oral administration of E. alsinoides and C. asiatica ethanolic extracts, i.e. EEA 300, EEA 600, EEA 1200, EEA 2000, ECA 300, ECA 600, ECA 1200 & ECA 2000 mg/kg doses showed no moral toxicity effect in LD50, acute and sub-acute toxicity parameters. CONCLUSION In this study, we had found that E. alsinoides & C. asiatica extract at different doses cause no mortality in acute and sub-acute toxicity study. Also, histopathology of kidney, liver, heart, and brain showed no alterations in tissues morphology.
Collapse
Affiliation(s)
- Mukesh Kumar Yadav
- Department of Kayachikitsa, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Santosh Kumar Singh
- Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Manish Singh
- Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Shashank Shekhar Mishra
- Department of Vikriti Vigyan, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Anurag Kumar Singh
- Centre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Jyoti Shankar Tripathi
- Department of Kayachikitsa, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| | - Yamini Bhusan Tripathi
- Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
| |
Collapse
|
17
|
Mishra SS, Yadav T, Mukhopadhyay N, Srivastava O. Nano-skeletal formation from decagonal quasicrystalline surface. Acta Crystallogr A Found Adv 2017. [DOI: 10.1107/s2053273317083814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
18
|
Kumar N, Mishra SS, Sharma CS, Singh HP, Kalra S. In silico binding mechanism prediction of benzimidazole based corticotropin releasing factor-1 receptor antagonists by quantitative structure activity relationship, molecular docking and pharmacokinetic parameters calculation. J Biomol Struct Dyn 2017; 36:1691-1712. [PMID: 28521603 DOI: 10.1080/07391102.2017.1332688] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Despite the various research efforts toward the treatment of stress-related disorders, the drug has not yet launched last 20 years. Corticotropin releasing factor-1 receptor antagonists have been point of great interest in stress-related disorders. In the present study, we have selected benzazole scaffold-based compounds as corticotropin releasing factor-1 antagonists and performed 2D and 3D QSAR studies to identify the structural features to elucidating the binding mechanism prediction. The best 2D QSAR model was obtained through multiple linear regression method with r2 value of .7390, q2 value of .5136 and pred_r2 (predicted square correlation coefficient) value of .88. The contribution of 2D descriptor, T_2_C_1 was 60% (negative contribution) and 4pathClusterCount was 40.24% (positive contribution) in enhancing the activity. Also 3D QSAR model was statistically significant with q2 value of .9419 and q2_se (standard error of internal validation) value of .19. Statistical parameters results prove the robustness and significance of both models. Further, molecular docking and pharmacokinetic analysis was performed to explore the scope of investigation. Docking results revealed that the all benzazole compounds show hydrogen bonding with residue Asn283 and having same hydrophobic pocket (Phe286, Leu213, Ile290, Leu287, Phe207, Arg165, Leu323, Tyr327, Phe284, and Met206). Compound B14 has higher activity compare to reference molecules. Most of the compounds were found within acceptable range for pharmacokinetic parameters. This work provides the extremely useful leads for structural substituents essential for benzimidazole moiety to exhibit antagonistic activity against corticotropin releasing factor-1 receptors.
Collapse
Affiliation(s)
- Neeraj Kumar
- a Department of Pharmaceutical Chemistry , Geetanjali College of Pharmacy , Udaipur 313001 , India
| | - Shashank Shekhar Mishra
- b Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy , Bhupal Nobles' University , Udaipur 313001 , India
| | - Chandra Shekhar Sharma
- b Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy , Bhupal Nobles' University , Udaipur 313001 , India
| | - Hamendra Pratap Singh
- b Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy , Bhupal Nobles' University , Udaipur 313001 , India
| | - Sourav Kalra
- c Centre for Human Genetics & Molecular Medicine , Central University of Punjab , Bhatinda 151001 , India
| |
Collapse
|
19
|
Shekhar Mishra S, Sharma CS, Singh HP, Pandiya H, Kumar N. In silico ADME, Bioactivity and Toxicity Parameters Calculation of Some Selected Anti-Tubercular Drugs. ACTA ACUST UNITED AC 2016. [DOI: 10.24896/eijppr.2016661] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Tuberculosis, one of the most frequent infectious diseases, is caused by a mycobacterium tuberculosis bacteria and it infects several hundred million people each year, results in several million deaths annually. Because there is development of antibiotic resistance, the disease becomes incurable. So, in the absence of effective and potent drug with minimal resistance problems, the mortality rate increases annually. In this computational investigation, we performed In-silico ADME, bioactivity and toxicity parameters calculation of some selected anti-tuberculosis agents. To design a new molecule having good pharmacological profile, this study will provide the lead information.Key Words: Tuberculosis (TB), Bacillus Calmette-Guerin vaccine, TPSA, In Silico toxicity
Collapse
|
20
|
Biswas S, Hussain KJ, Das NPI, Russell BC, Satpathy KK, Mishra SS. Imprint of monsoonal patterns on the fish assemblage in coastal waters of south-east India: a case study. J Fish Biol 2014; 85:773-799. [PMID: 25053000 DOI: 10.1111/jfb.12461] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/07/2013] [Accepted: 05/27/2014] [Indexed: 06/03/2023]
Abstract
The composition, species richness and diversity of a coastal fish assemblage from the Kalpakkam coast of south-east India are described along with temporal distribution patterns related to seasonal fluctuations in dissolved oxygen, salinity, pH, chlorophyll-a, phytoplankton and zooplankton species richness and density. A total of 244 fish species belonging to 21 orders, 87 families and 163 genera were recorded. The fish assemblage was dominated by reef-associated species, followed by demersal species. The majority of the species (63%) are widely distributed in the western Indo-Pacific as well as in the central Indo-Pacific. Jaccard's coefficient analysis showed three distinct seasonal patterns of fish occurrence: pre-monsoon (PrM), monsoon (M) and post-monsoon (PoM). The maximum number of species was during the PrM period, followed by the PoM and M periods. Species occurrence analysis showed Sardinella longiceps to be dominant during PrM and M periods, Leiognathus dussumieri during the M period and Secutor insidiator and Secutor ruconius during the M and PoM periods. Canonical correspondence analysis indicated that salinity and rainfall were the two most influential environmental factors strongly correlated with temporal variation in the fish assemblage. The physico-chemical conditions, in combination with factors such as greater food availability and shelter, might control the seasonal local distribution of the ichthyofauna in these Indian coastal waters.
Collapse
Affiliation(s)
- S Biswas
- Environment & Safety Division, Radiological Safety & Environmental Group, Electronics Instrumentation & Radiological Safety Group, Indira Gandhi Centre for Atomic Research, Kalpakkam, Tamil Nadu 603102, India
| | | | | | | | | | | |
Collapse
|
21
|
Swain P, Nayak SK, Sasmal A, Behera T, Barik SK, Swain SK, Mishra SS, Sen AK, Das JK, Jayasankar P. Antimicrobial activity of metal based nanoparticles against microbes associated with diseases in aquaculture. World J Microbiol Biotechnol 2014; 30:2491-502. [PMID: 24888333 DOI: 10.1007/s11274-014-1674-4] [Citation(s) in RCA: 63] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2013] [Accepted: 05/20/2014] [Indexed: 12/18/2022]
Abstract
The emergence of diseases and mortalities in aquaculture and development of antibiotics resistance in aquatic microbes, has renewed a great interest towards alternative methods of prevention and control of diseases. Nanoparticles have enormous potential in controlling human and animal pathogens and have scope of application in aquaculture. The present investigation was carried out to find out suitable nanoparticles having antimicrobial effect against aquatic microbes. Different commercial as well as laboratory synthesized metal and metal oxide nanoparticles were screened for their antimicrobial activities against a wide range of bacterial and fungal agents including certain freshwater cyanobacteria. Among different nanoparticles, synthesized copper oxide (CuO), zinc oxide (ZnO), silver (Ag) and silver doped titanium dioxide (Ag-TiO2) showed broad spectrum antibacterial activity. On the contrary, nanoparticles like Zn and ZnO showed antifungal activity against fungi like Penicillium and Mucor species. Since CuO, ZnO and Ag nanoparticles showed higher antimicrobial activity, they may be explored for aquaculture use.
Collapse
Affiliation(s)
- P Swain
- Fish Health Management Division, Central Institute of Freshwater Aquaculture, Kausalyaganga, Bhubaneswar, 751002, India,
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
SM S, I S, Mishra SS, Y VR. Evaluation of hypoglycemic effect ofLagerstroemia speciosa(Banaba) Leaf extract in Alloxan induced diabetic rabbits. ACTA ACUST UNITED AC 2013. [DOI: 10.5958/j.2319-5886.2.2.033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
23
|
Arulprakash S, Verma SP, Bhardwaj VK, Mishra SS, Chansoria M. Brain stem auditory evoked responses and visual evoked responses in children with tubercular meningitis. Indian Pediatr 2006; 43:631-4. [PMID: 16891684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
Thirty two patients between 6 months and 14 years of age with tubercular meningitis were evaluated for brain stem auditory evoked response (BAER) and Visual evoked responses (VER), within 7 days of admission. Absolute latencies and interpeak latencies were compared with values obtained from normal children. BAER abnormality was found in 56.25% and VER in 28%children, respectively. BAER abnormality correlated with Glasgow Coma Scale at admission and discharge, stage of meningitis, raised intracranial pressure, seizure activity, and poor outcome. VER abnormality correlated with abnormal fundus findings only.
Collapse
Affiliation(s)
- S Arulprakash
- Department of Pediatrics and Physiology, NSCB Medical College, Jabalpur, Madhya Pradesh 482 003, India
| | | | | | | | | |
Collapse
|
24
|
Mishra SS, Shekhar MS. White spot syndrome virus isolates of tiger shrimp Penaeus monodon (Fabricious) in India are similar to exotic isolates as revealed by polymerase chain reaction and electron microscopy. Indian J Exp Biol 2005; 43:654-61. [PMID: 16053274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
Microbiological analysis of samples collected from cases of white spot disease outbreaks in cultured shrimp in different farms located in three regions along East Coast of India viz. Chidambram (Tamil Nadu), Nellore (Andhra Pradesh) and Balasore (Orissa), revealed presence of Vibrio alginolyticus, Vibrio parahaemolyticus, and Aeromonas spp. but experimental infection trials in Penaeus monodon with these isolates did not induce any acute mortality or formation of white spots on carapace. Infection trials using filtered tissue extracts by oral and injection method induced mortality in healthy P. monodon with all samples and 100% mortality was noted by the end of 7 day post-inoculation. Histopathological analysis demonstrated degenerated cells characterized by hypertrophied nuclei in gills, hepatopancreas and lymphoid organ with presence of intranuclear basophilic or eosino-basophilic bodies in tubular cells and intercellular spaces. Analysis of samples using 3 different primer sets as used by other for detection of white spot syndrome virus (WSSV) generated 643, 1447 and 520bp amplified DNA products in all samples except in one instance. Variable size virions with mean size in the range of 110 x 320 +/- 20 nm were observed under electron microscope. It could be concluded that the viral isolates in India involved with white spot syndrome in cultured shrimp are similar to RV-PJ and SEMBV in Japan, WSBV in Taiwan and WSSV in Malaysia, Indonesia, Thailand, China and Japan.
Collapse
Affiliation(s)
- S S Mishra
- Central Institute of Brackishwater Aquaculture, 75, Santhome High Road, R.A.Puram, Chennai 600 028, India.
| | | |
Collapse
|
25
|
Singh N, Valecha N, Nagpal AC, Mishra SS, Varma HS, Subbarao SK. The hospital- and field-based performances of the OptiMAL test, for malaria diagnosis and treatment monitoring in central India. Ann Trop Med Parasitol 2003; 97:5-13. [PMID: 12662417 DOI: 10.1179/000349803125002544] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
The performance of the OptiMAL test, to detect and differentiate Plasmodium falciparum and P. vivax, was evaluated in central India. The subjects were either symptomatic patients, who presented at a referral hospital in urban Jabalpur, or the inhabitants of remote, tribal, forested villages where malaria is a major public-health problem. In each setting, the results of conventional microscopy were used as the 'gold standard'. Under hospital conditions, the test had excellent sensitivity (100%), good specificity (97%), a high positive predictive value (98%) and a high negative predictive value (100%). The corresponding values in the field-based study in the tribal villages (100%, 67%, 84% and 100%, respectively) were almost as good. The results of OptiMAL testing reveal the decline in parasitaemias (of P. falciparum or P. vivax) after drug administration. For monitoring the effectiveness of treatment, the test could therefore be a useful alternative to microscopy, particularly (1) in places where the facilities for microscopy are poor or non-existent and (2) among hospitalized patients with severe, complicated malaria (in whom parasitaemia and drug response need to be followed very carefully). Follow-up (within 28 days of diagnosis) of the 58 malaria cases detected in the field revealed that the OptiMAL test can be used to detect re-infection with a different Plasmodium sp. (sensitivity = 100%; specificity = 100%; J-index = 1) or recrudescence/re-infection with the same Plasmodium sp. (sensitivity = 83%; specificity = 100%; J-index = 0.83) accurately. The ability to use the test to distinguish P. falciparum from P. vivax, and to identify mixed infections of these two species, is of great significance in areas where the preferred and effective therapy for P. falciparum malaria differs from that for P. vivax.
Collapse
Affiliation(s)
- N Singh
- Malaria Research Centre (Field Station), NSCB Medical College Building, Jabalpur-482003, India.
| | | | | | | | | | | |
Collapse
|
26
|
Jena S, Mishra SS. Lupus vulgaris on keloid. Indian J Dermatol Venereol Leprol 2002; 68:147-8. [PMID: 17656915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
A 28-year-old man presented with multicentric lupus vulgaris on keloids over chest, axilla, neck and back for last 6 months. He had pulmonary tuberculosis. All the laboratory investigations were in favour of clinical diagnosis. The patient responded to antituberculosis therapy.
Collapse
Affiliation(s)
- S Jena
- Department of Dermatology and Venereology, VSS Medical College, Burla, Sambalpur-768 017, Orrisa, India
| | | |
Collapse
|
27
|
Abstract
Indian Armed Forces are constrained to deploy a large number of troops in the western Himalayas in the interest of national security and territorial integrity. The region represents extremely rugged, arid and cold climatic conditions. The altitude ranges from 8000 to 23000 feet with winter temperatures ranging from -35°C to - 55°C in some regions. Low environmental humidity, hypo-baric hypoxia and high solar ultra-violet radiation with its attendant problems further compound the hardships faced by the troops in these climatic conditions. The role of the Armed Forces medical personnel is extremely challenging, as they have to ensure maintenance of health and physical fitness of the troops to ensure optimal performance during peace and during operations. These considerations include nutrition, physical fitness programmes suitable for the terrain and climatic conditions, protection against cold and hypoxia induced health problems, clothing and shelter taking into consideration the ergonomic factors, human waste disposal and prompt medical attention and evacuation in case of illness. An overview of the effects of cold hypoxic environment on health and performance of Indian troops, measures employed by the Armed Forces to maintain health of troops including psychological factors and the incidence of various cold induced health problems during peace time compared to operational period over the last 10 years is presented in this paper.
Collapse
Affiliation(s)
- R Jayaswal
- Ex Director General, Armed Forces Medical Services, Colaba, Mumbai - 400 005
| | - P Sivadas
- Director Institute of Naval Medicine, Colaba, Mumbai - 400 005
| | - S S Mishra
- Professor and Head, Department of Physiology, Institute of Aerospace Medicine, Vimanpura, Bangalore - 560 017
| |
Collapse
|
28
|
Singh N, Mishra SS, Singh MP, Sharma VP. Seasonality of Plasmodium vivax and P. falciparum in tribal villages in central India (1987-1995). Ann Trop Med Parasitol 2000; 94:101-12. [PMID: 10827865 DOI: 10.1080/00034980057446] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Microscopical examination of blood films produced from samples collected, over a 9-year period (1987-1995), from the inhabitants of four tribal villages of Mandla district, Madhya Pradesh (central India) revealed that malaria was highly endemic and probably transmitted perennially. Both Plasmodium vivax and P. falciparum were prevalent in all age-groups but their prevalence was highly seasonal: longitudinal studies showed an autumn (October-November) peak for P. falciparum and a summer (April-May) peak for P. vivax. However, both the incidence and prevalence of infection with each Plasmodium species showed inter-village variations. Analysis of the malariometric parameters investigated revealed that there had been no improvement in the malaria situation over the study period, and that, since 1992, there had been a shift in the predominant parasite, from P. vivax to P. falciparum, in each village.
Collapse
Affiliation(s)
- N Singh
- Malaria Research Centre, Field Station (ICMR), Jabalpur, India
| | | | | | | |
Collapse
|
29
|
Swain TR, Das M, Kanungo S, Mukherji D, Mishra SS, Das MC. A comparative study on the effect of felodipine and propranolol on serum lipid profile of rabbits. Indian J Physiol Pharmacol 1997; 41:269-74. [PMID: 10232772] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/13/2023]
Abstract
Effect of felodipine on serum lipids of rabbits was studied and was compared with that of propranolol. Lipid parameters were estimated at basal (0 wk), end of 4th and 16th week of diet/drug administration by using standard kits for analysis. There was a significant increase in mean serum cholesterol, TG, VLDLc, LDLC and decrease in HDLc, (P<0.05) in the group of rabbits receiving Atherogenic diet (AD)/Propranolol. This effect was maximally observed in rabbits receiving both AD and propranolol. This change was satisfactorily prevented when felodipine was administered from very beginning (P<0.001). In addition, there was a significant increase in HDLc (28.89%) of rabbits receiving felodipine from beginning. Thus both AD and propranolol have dyslipidemic effect and early administration of felodipine favorably changes all lipid parameters.
Collapse
Affiliation(s)
- T R Swain
- P.G. Department of Pharmacology, S.C.B. Medical College, Cuttack
| | | | | | | | | | | |
Collapse
|
30
|
Mishra SS, Mallick BB. Restriction fragment analysis of fowlpox virus using Bgl I, Bam HI, Hha I and Sma I restriction endonucleases. Indian J Exp Biol 1996; 34:959-63. [PMID: 9055646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Fowlpox virus vaccine strain and two field isolates collected from out breaks of disease were purified from cell culture using sucrose gradient ultracentrifugation. The viral DNAs were digested with Bgl I, Bam HI, Hha I and Sma I restriction endonucleases and the fragment pattern was analysed on 0.7% agarose gel. Bgl I digestion produced 54 fragments of size ranging from 31.50 to 0.60 kb, having similar electrophoretic mobilities in both the vaccine strain and two field isolates. Only 9 well resolved and one unresolved or partially digested fragment were obtained after Bam HI digestion. A total number of 29 and 41 fragments were obtained with Hha I and Sma I respectively. Almost similar restriction fragment pattern was observed in vaccine strain and the field isolates. The total genomic size was calculated to be between 265.00 and 302.91 kb. The three viruses were found to be genetically similar.
Collapse
Affiliation(s)
- S S Mishra
- Indian Veterinary Research Institute, Izatnagar, India
| | | |
Collapse
|
31
|
Mishra SS, Mallick BB. Fowlpox virus structural protein immunogens and characterization of single band polypeptide. Indian J Exp Biol 1996; 34:311-6. [PMID: 8698419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
A fowlpox virus isolate obtained from an outbreak of disease in a vaccinated poultry flock was propagated in chicken embryo fibroblast cell culture. Analysis of purified virus polypeptide on 7.5-15% gradient polyacrylamide gel revealed 45 structural polypeptides after Coomassie blue staining. The mol.wt. of polypeptides ranged between 225.53 and 10.50 kDa with total mol.wt. of 2650 kDa. Variable numbers of immunogenic virion polypeptides were detected in immunoblot with fowlpox virus infected chicken sera collected at different time intervals. A total of 29 polypeptides reacted with sera collected at 1st week post-infection and the number gradually declined to 27, 26, 20, 17 and 15 when reacted with 2nd, 3rd, 4th, 5th and 6th week post-infection sera, respectively. Reaction with fowlpox virus hyperimmune sera revealed 35 immunogenic polypeptides. A number of major and minor immunogens were detected. Antisera against seven major single band polypeptides including one double band polypeptide showed very low reactivity both in ELISA and serum neutralization test. Involvement of multigenic components in virus neutralization is indicated.
Collapse
Affiliation(s)
- S S Mishra
- Indian Veterinary Research Institute, Izatnagar, India
| | | |
Collapse
|
32
|
Mishra SS, Mallick BB. Comparative immunological and genomic characterization of fowlpox virus isolates. Indian J Exp Biol 1996; 34:11-7. [PMID: 8698401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Chickens infected with fowlpox virus (FPV) IVRI vaccine strain and two field isolates collected from clinical cases of disease (Bareilly isolate and Panchmahal isolate) produced humoral antibody response after 2nd week post-infection, with a noticeable variation in degree of immune response. Serum antibody titre peaked at 4th week post-infection with a titre of 25,600, 25,600 and 51,200 being detected in ELISA and neutralization index of 2.75, 2.43 and 3.12 in serum neutralization test (SNT) with IVRI vaccine strain, Panchmahal isolate and Bareilly isolate, respectively. Cellular immune response was detected as early as 1st week post-infection by leukocyte migration inhibition test (LMIT). Per cent migration inhibition too peaked at 4th week with a value of 40.30 +/- 3.45, 36.93 +/- 4.11 and 45.45 +/- 3.66 being detected with the three viruses respectively. The Hind III and Hae III restriction fragment profile of viral DNA showed almost similar pattern both in vaccine strain and two field isolates. Hind III digestion produced 47 well resolved fragments of sizes between 24.30 and 1.20 kb and the total genomic size was estimated to be between 305.81 and 306.06 kb. Hae III digestion revealed 34 well resolved fragments of sizes between 27.55 and 1.32 kb. The three viruses could not be differentiated on the basis of their genomic restriction pattern. However immunogenic and antigenic differences were noticed by ELISA and SNT tests.
Collapse
Affiliation(s)
- S S Mishra
- Indian Veterinary Research Institute, Bareilly, India
| | | |
Collapse
|
33
|
Mishra SS, Mallick BB. Structural proteins of fowlpox virus vaccine strain and field isolates. Indian J Exp Biol 1994; 32:826-31. [PMID: 7896313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Structural polypeptides of IVRI vaccine strain and two field isoaltes of Fowlpox virus (Bareilly isolate and Panchmahal isolate) were analysed on SDS-PAGE and by immunoblotting technique. In 5%-20% gradient acrylamide gel 31, 29 and 31 polypeptide bands and in 7.5%-15% gradient gel 45, 37 and 39 polypeptide bands were detected after Coomassie blue staining respectively for Bareilly isolate, Panchmahal isolate and IVRI vaccine strain. The molecular weight (MW) of the polypeptides ranged from 226.10 to 10.30 kDa with total MW of 2650.12, 2259.50, and 2378.68 kDa respectively for the three viruses. The immunoblot revealed 35, 29 and 30 immunogenic polypeptides indicating most virion polypeptides to be immunogenic in nature. Although most polypeptides had similar electrophoretic pattern both in SDS-PAGE and immunoblotting, still the three viruses could be differentiated. The viruses were found to be antigenically different with Panchmahal isolate lacking the polypeptides 81.15, 76.33, 39.30, 37.50 and 29.35 kDa and the vaccine strain lacking 76.33, 37.50 and 29.35 kDa polypeptides as were present in Bareilly isolate.
Collapse
Affiliation(s)
- S S Mishra
- Indian Veterinary Research Institute, Izatnagar
| | | |
Collapse
|
34
|
Gupta PP, Pandey DN, Pandey DJ, Sharma AL, Srivastava RK, Mishra SS. Aspirin in experimental cataractogenesis. Indian J Med Res 1984; 80:703-7. [PMID: 6532973] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
|
35
|
Gupta PP, Pandey DJ, Sharma AL, Srivastava RK, Mishra SS. Prevention of experimental cataract by alpha-tocopherol. Indian J Exp Biol 1984; 22:620-2. [PMID: 6534851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
36
|
Dash R, Panda R, Mishra SS, Das PC, Mishra KC. Levamisole in recurrent aphthous stomatitis. J Indian Med Assoc 1983; 80:140-1. [PMID: 6644050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
|
37
|
Dhir GG, Mohan G, Verma RB, Mishra SS. Studies on the Antifungal Activity of Pterocarpus Marsupium: a Clinical Evaluation. Indian J Dermatol Venereol Leprol 1982; 48:154-156. [PMID: 28193944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Pmarsupium (Hindi Bijasar) is a powerful astringent and is used chiefly in diarrhoeas. It is also an useful remedy for diabetes mellitus and various skin diseases as mentioned in literature. In a blind clinical trial, the usefulness of this drug as a topical agent against T.cruris and T. corporis was elevated. The drug yielded good response within 3 days of the first application.
Collapse
|
38
|
Gupta RP, Mishra SS, Sinha BK, Sinha VK. Studies on experimental infection of "Escherichia coli" in chicks. Ann Sclavo 1980; 22:363-9. [PMID: 7018416] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
39
|
Mishra SS, Dwivedi MP. An epidemiological study of filariasis in Rewa town (M.P.). Indian J Public Health 1979; 23:7-16. [PMID: 468368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
|
40
|
Sinha VK, Mishra SS, Sinha BK, Sinha AK, Verma SP. Efficacy of "Vetalog" against non-specific canine dermatoses. Indian Vet J 1978; 55:1014-5. [PMID: 751965] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
41
|
Talwar P, Mishra SS, Dash RJ. Case report: Disseminated histoplasmosis. INDIAN J PATHOL MICR 1978; 21:357-60. [PMID: 750473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
|
42
|
Singh RP, Mishra SS. Studies on the preparation of rinderpest antigen for use in conglutinating complement absorption test. Indian Vet J 1978; 55:643-7. [PMID: 738787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
43
|
Kishore S, Sharma AL, Mishra SS. Effect of glucagon on some isolated venous preparations. Indian J Med Res 1977; 66:692-5. [PMID: 608736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
|
44
|
Ansari KU, Mishra SS, Chandra V. Modification of vascular response to synthetic oxytocin by oestrogen in rabbit. Indian J Physiol Pharmacol 1977; 21:195-8. [PMID: 612602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Intravenously administered oxytocin caused a dose-related fall in blood pressure of the rabbit. When oxytocin was administered in oestrogen-primed animals, the depressor response was converted to a pressor one "Oxytocin reversal". The "oxytocin reversal." was abolished after treatment with dihydroergotamine, hexamethonium or adrenalectomy. The "oxytocin reversal" did not appear in reserpinized animals.
Collapse
|
45
|
Mathur U, Sharma AL, Mishra SS, Mathur SK. Effect of rifampicin on serum cholesterol levels in rabbits after experimental hypercholesterolaemia. J Indian Med Assoc 1977; 68:203-5. [PMID: 903620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
46
|
Mishra KC, Mishra SS. A study of the effects of corticosteroids on blood coagulation in rabbits. Indian J Med Sci 1971; 25:154-157. [PMID: 5576738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
47
|
Bapat SK, Jauhari AC, Mishra SS, Ansari KU, Chandra V. Antipermeability effects of some corticosteroids. Indian J Med Sci 1970; 24:737-41. [PMID: 5490365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
48
|
Verma BB, Mishra SS, Das UL. Renal diabetes like syndrome in a bullock. Indian Vet J 1970; 47:84-5. [PMID: 5462216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
49
|
Mishra KC, Mishra SS. Effect of oral contraceptives on the blood coagulation in experimental animals. Indian J Med Res 1969; 57:1734-7. [PMID: 5369795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
|
50
|
Sharma M, Mishra SS. A pharmacological study of some abortifacient plants. Indian J Physiol Pharmacol 1969; 13:139-41. [PMID: 5391431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|